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REGION BASED GENE EXPRESSION VIA REANALYSIS OF PUBLICLY 
AVAILABLE MICROARRAY DATA SETS 
Ernur Saka 
April 20, 2018 
 A DNA microarray is a high-throughput technology used to identify relative gene 
expression. One of the most widely used platforms is the Affymetrix® GeneChip® 
technology which detects gene expression levels based on probe sets composed of a set of 
twenty-five nucleotide probes designed to hybridize with specific gene targets.  
 Given a particular Affymetrix® GeneChip® platform, the design of the probes is 
fixed. However, the method of analysis is dynamic in nature due to the ability to annotate 
and group probes into uniquely defined groupings. This is particularly important since 
publicly available repositories of microarray datasets, such as ArrayExpress and NCBI’s 
Gene Expression Omnibus (GEO) have made millions of samples readily available to be 
reanalyzed computationally without the need for new biological experiments. One way in 
which the analysis can dynamically change is by correcting the mapping between probe 
sets and targets by creating custom Chip Description Files (CDFs) to arrange which probes 




 Since default probe sets in Affymetrix® GeneChip® platforms are specific for a 
gene, transcript or exon, the analyses are then limited to profile differential expression at 
the gene, transcript or individual exon level. However, it has been revealed that 
untranslated regions (UTRs) of mRNA have important impacts on the regulation of 
proteins.  
 We therefore developed a new probe mapping protocol that addresses three issues 
of Affymetrix® GeneChip® data analyses: removing nonspecific probes, updating probe 
target mapping based on the latest genome information and grouping the probes into region 
(UTR, individual exon), gene and transcript level targets of interest to support a better 
understanding of the effect of UTRs and individual exons on gene expression levels. 
Furthermore, we developed an R package, affyCustomCdf, for users to dynamically create 
custom CDFs. The affyCustomCdf tool takes annotations in a General/Gene Transfer 
Format File (GTF), aligns probes to gene annotations via Nested Containment List 
(NCList) indexing and generates a custom Chip Description File (CDF) to regroup probes 
into probe sets based on a region (UTR and individual exon), transcript or gene level.  
Our results indicate that removing probes that no longer align to the genome 
without mismatches or align to multiple locations can help to reduce false-positive 
differential expression, as can removal of probes in regions overlapping multiple genes. 
Moreover, our method based on regions can detect changes that would have been missed 
by analysis based on gene and transcript. It also allows for a better understanding of 3’ 
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 Photo 51, the first X-ray diffraction image of DNA produced by Rosalind Franklin 
in 1952, triggered the discovery of the DNA helix structure by James D. Watson and 
Francis H. C. Crick in 1953. Subsequently, the first DNA polymerase was identified by 
Arthur Kornberg in 1957. After the discovery of the DNA structure and the DNA 
replication mechanism, researchers started working on gene expression analysis and 
protein synthesis [1], leading to the current day fields of molecular biology and 
bioinformatics. 
 Gene expression analysis studies the entire process of a particular worker molecule 
production from the coding information contained in DNA. Technologies developed for 
gene expression studies have had a huge impact on the field. Southern blotting developed 
by Edward M. Southern and Sanger sequencing developed by Frederick Sanger enabled 
researchers to locate particular gene or DNA samples in the genome. Northern blotting 
developed by James Alwine and George Stark allowed detection of specific mRNA in a 
geometric sample. Exponential amplification of DNA segments became possible via the 
polymerase chain reaction (PCR) technique developed by Kary Mullis. The development 
of microarrays allowed researchers to investigate thousands of gene products in parallel. 
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One of the most widely used microarray platforms is the Affymetrix® GeneChip® 
family of arrays. It detects gene expression levels based on probe sets composed of a set of 
individual 25 base probes designed to hybridize with the specific gene targets. This 
research mainly focuses on the creating a framework for computationally reanalysis of 
publicly available Affymetrix® GeneChip® data based on region (UTR and individual 
exon), gene and transcript through remapping probes to gene targets with created custom 
Chip Description Files (CDFs). The custom CDF creation involves removing nonspecific 
probes, updating probe target mapping based on the latest genome information, grouping 
probes into region, gene or transcript level targets and saving updated probe-target groups 
into a CDF. The unspecified probes were identified based on the mapping of probe 
sequences to the genome of interest. Probe target mapping was accomplished by aligning 
specific probes to genomic intervals obtained from general/gene transfer format file via 
Nested Containment List (NCList) indexing. Our custom CDFs provide a way to 
investigate changes appeared in the untranslated regions and exons of mRNA which data 
has not been performed on a large scale with microarray datasets in addition to gene and 
transcript. We also supply flexibility for creating gene of interest CDFs by allowing user 
to supply annotations via GTF files.  
1.1 Motivation 
Our research has been motivated by the following goals: 
1) Improving the accuracy of microarray by using up-to-date genomes and annotations. 
 Given a particular Affymetrix® GeneChip® platform, the design of the probes is 
fixed based on earlier genome assemblies and annotation available at that time. Since the 
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design of the first Affymetrix® GeneChip®, rapid progress has been made in genome 
sequencing resulting in more accurate databases of annotated protein coding and non-
coding structural genes. The significant differences between old and new genome 
assemblies and annotations make it necessary to update probe-gene targeting according to 
current knowledge to get more accurate interpretations from experimental results. 
Affymetrix® attempts to provide compatibility between genomic changes by updating 
links between probe sets and their corresponding genes/transcripts via NetAffx™[2]. Table 
1 shows release dates of source databases used by Affymetrix® version 36 for both the 
incorporated version and the most recently available version. In all cases, there is at least 
three-year difference between the incorporated and most recent release dates which can 
lead to inconsistent interpretation. 
 In addition, updating links between probe sets and their corresponding 
genes/transcripts does not provide a solution for problems caused by individual probes such 
as single nucleotide polymorphisms (SNPs) [3, 4] probes that target genes other than the 
designated gene of a probe set, and probes that no longer align to a genomic location due 
to refinements in genome assemblies.  For example, in the Affymetrix® GeneChip® HG-
133 Plus 2 array, a total of 40,680 probes out of 603,158 (excluding quality control probes) 
do not have a perfect match to the most recent human genome assembly (hg38). 
 Although the inherent effects of using dated probe gene mapping designs to 
analyze microarray data sets might seem obvious, the overwhelming majority of 
experimental results have only been analyzed using the original CDFs designed by 
Affymetrix®. For example, as of May 2016, GEO has 120,920 samples which were 
analyzed via the original Affymetrix® CDFs for the HG-U133 Plus 2 array (Table 2). On 
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the other hand, only 6,403 samples were analyzed using custom CDFs, mostly produced 
by brainarray (Table 3). Given that fewer than 5% of all samples in GEO have been 
analyzed by alternative CDFs, an opportunity exists to reanalyze existing datasets 
according to updated transcript knowledge or functional regions of interest. 
TABLE 1: Release dates of databases used by NetAffx v36 annotations and current 
database versions 
GEO Platform Organism 
GPL570 Homo sapiens 
GPL1261 Mus musculus 
GPL1355 Rattus norvegicus 
GPL198 Arabidopsis thaliana 
Incorporation Data of Databases Common to All Four GEO Platforms 
 Ensembl RefSeq GenBank Entrez Gene 
NetAffx Nov-15 Nov-15 Nov-15 Nov-15 
Apr-18 Current Apr-18 Mar-18 Feb-18 
  
TABLE 2: Top Affymetrix® in situ oligonucleotide arrays found in GEO 
GEO 
Platform 
Title # of Probes # of Probe Sets # of 
Samples 
GPL570 Human Genome U133 Plus 
2.0 Array 
604,258 54,675 120,920 
GPL1261 Mouse Genome 430 2.0 
Array 
496,468 451,01 480,87 
GPL1355 Rat Genome 230 2.0 Array 342,410 310,99 189,12 
GPL198 Arabidopsis ATH1 Genome 
Array 
251,078 228,10 126,24 
 




# of Alternative 
CDFs 
# and percent of Samples 
Using Alternative CDFs 
GPL570 54 6403 (5.0%) 
GPL1261 36 1984 (4.0%) 
GPL1355 12 460 (2.4%) 




2) Understanding the effect of untranslated regions on gene expression levels furthermore 
on diseases. 
In molecular biology, even though the scaffolds of the proteins are defined by 
genomic DNA during transcription, they are actually synthesized during translation based 
on the intermediary template messenger mRNA using the genetic code. But regulation of 
genes, which functions in the selection of produced proteins, can occur at the 
transcriptional or translational level [5]. Transcription level regulation occurs through 
complexes that form at transcription factor binding sites which typically found within 5′ 
UTRs, the upstream region of the transcription start site (TSS). On the other hand, 3’ UTRs, 
which are downstream of the coding region, serve as a binding site for many translational 
control mechanisms.  
While microarrays have been successfully utilized for understanding differential 
expression at the gene or probe set level, less attention has been given to the potential 
analysis at the individual exon, alternative transcript, and untranslated region (UTR) level. 
Although the selection bias of probes on the 3’ ends of genes for earlier iterations of 
Affymetrix® GeneChip® designs presents limitations on the completeness of transcript 
information, more recent designs allow for a more complete coverage of exons and exon 
junctions. However, information concerning individual exons can still be extracted from 
earlier GeneChip® designs, particularly in the 3’ UTR regions. 
• 3′ Untranslated Regions (UTRs) association with gene regulation 
  3′ UTRs contains translational control mechanisms that include miRNA binding 
sites, AU rich elements (AREs), cytoplasmic polyadenylation element (CPE) binding sites, 
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localization binding elements, zipcode binding proteins and G-quadruplex sites. Through 
these mechanisms, 3′ UTRs play important role in development [6-10] embryonic axis 
formation, neurogenesis, erythropoiesis, localization in the nervous system [11-16]   and 
cancer [17-19]. For example, cytoplasmic polyadenylation [20], which is a modification of 
mRNA transcripts in the form of  polyadenylated  (poly(A)) tails, plays an important role 
in transcription level regulation, indicating that alternative splicing in the 3′ UTR might be 
associated with the changes in the coding regions thus structural changes within the 3′ UTR 
will affect the expression level and localization of a gene. Over 40% of genes have been 
shown to generate multiple mRNAs with variable 3′ UTR lengths [21]. These 3′ UTRs 
harbor binding sites for molecules including microRNAs (miRNAs) and RNA-binding 
proteins. Thus, mRNA isoforms with lengthened 3′ UTRs have increased numbers of sites 
for these cis-interacting factors. The diversity of 3′ UTRs is predominantly regulated by 
alternative polyadenylation (APA), which employs alternative mRNA cleavage sites that 
lie progressively distal to the stop codon. APA-driven mRNA diversity is required for 
normal physiology, and misregulation of this process is associated with diverse disease 
state [22]. It is known that the length of the 3′ UTR (short and long 3’ UTRs) plays an 
important role in localization of brain-derived neurotrophic factor (BDNF) transcripts. 
Short 3′ UTR mRNAs are often localized in somata, while long 3′ UTR mRNAs localized 
in dendrites [23]. Lengthening of 3′ UTRs has an effect during development. A study has 
shown that in the mouse brain during embryonic and postnatal development, mRNAs have 
longer 3’ UTRs than other tissues [7]. Shortening of 3′ UTRs also plays an important role. 
It has been shown that tumors with shorter 3’ UTRs are more aggressive in nature, and 3’ 
UTRs expression signatures are being used as strong predictors of survival [24]. The 
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mutations within the 3’ UTR affect the termination codon, polyadenylation signal and 
change the secondary structure of the 3’ UTR. For example, aniridia disease resulting 
partial in or complete loss of the iris is associated with the mutation in the stop codon (TAA 
 TTA) located within the 3’ UTR of the PAX6 gene [25]. 
• 5′ Untranslated Regions (UTRs) association with gene regulation 
The 5’ UTR is a regulatory region located at the 5’ end of the mRNA [26]. Some 
of the 5’ UTR regulatory elements which cause abnormal cell function are 5’ UTR length, 
5’cap structure, secondary structure, mutation in the 5’ UTR and uORFs (upstream open 
reading frames). For example it was shown that the BRCA1 gene, which acts as a tumor 
suppressor, is downregulated by a G to C mutation within the 5’ UTR of the gene itself 
[25].  
3) Taking advantage of available data in public repositories. 
 Since microarrays were introduced in 1995, different platforms have been 
developed and used to perform lab experiments. Over two million different samples have 
been produced and submitted to publicly available repositories. One of the most known 
and used repositories in international public high-throughput functional genomics is the 
Gene Expression Omnibus (GEO). As of April 2018, GEO has 2,455,165 samples, 97,014 
series and 4,348 data sets. Each sample contains original experiment results under the 
specific conditions supplied by submitter. A series is a group of related samples with the 
summary of the experiment, conclusions and analysis. A data set is composed of curated 
records produced by GEO staff by reassembling biologically and statistically comparable 
GEO samples.  
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In microarray technology, even though the design of the probes is fixed, the 
methods with which the resulting experiments can be analyzed are dynamic in nature due 
to the ability to annotate and arrange probes into uniquely defined groupings. This is 
particularly important since GEO contains 29,930 samples produced by Affymetrix® 
GeneChips® platform as of April 2018 that can be reanalyzed computationally based on 
current knowledge without the need for new biological experiments. As a case in point, 
each of the four most commonly used species have samples that have been analyzed using 
the original CDFs (Table 2).  
1.2 Organization of the Document 
 This dissertation is organized in 9 chapters. Chapter 2 is a brief overview of 
molecular biology. It begins with an introduction followed by the main genetic molecules 
DNA, RNA and protein. Next it explains gene, gene regions and the gene expression 
mechanism. It continues with the central dogma, genetic information transfer and genetic 
code. It ends with alternative splicing and noncoding DNA regions. Chapter 3 explains 
microarrays which mainly focuses on the Affymetrix® GeneChip® platform. It starts with 
a history of gene expression tools before microarrays and continues with the basis of 
microarrays; hybridization, design of DNA microarray lab experiments and type of DNA 
microarray technologies. Next it explains the Affymetrix® GeneChip® technology and 
ends with the data file types. Chapter 4 is the literature review of custom CDFs. It starts 
with a motivation for the used custom CDFs and summaries the custom CDF design steps 
of previously published works. Chapter 5 explains the alignment tool Bowtie, the interval 
tree data structure and nested containment list indexing. Chapter 6 explains the protocol 
used to create our custom CDFs. It starts with the removal of unspecific probes, continues 
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with annotation of probes via NCList indexing and ends with probe set naming inside the 
custom CDF file. Chapter 7 explains the developed R package affyCustomCdf and a 
variety of files that can be created via the affyCustomCdf tool. Chapter 8 gives the 
statistical and analysis results of produced human, rat and mouse custom CDFs. It also 
presents the comparisons between our results, previous work and comparisons between 
different types of our custom CDFs via reanalyzing publicly available microarray datasets. 
Chapter 9 discusses the contributions and post dissertation work. Appendix A provides 
steps for using the developed R package affyCustomCdf.  
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CHAPTER 2  
OVERVIEW OF MOLECULAR BIOLOGY 
 Molecular biology is the field of study that involves studying cell structure and 
function down to the level of the individual molecules within those cells that contain the 
programming for life functions [27]. Cells are the smallest living things and the basic unit 
of any living organisms. They have all the properties of life such as reproduction, response 
to environment signals, a need for energy, and release of waste products. All cells are built 
out of similar materials (including an organism’s DNA) and function in similar ways. 
Prokaryotic cells, such as bacteria and some single celled organisms, have simple 
organization. They do not have a true membrane-bound nucleus and organelles. Eukaryotic 
cells, such as plants, animals, and fungi are structurally complex. They contain a 
membrane-bound nucleus and organelles. 
 The nucleus is a small spherical, dense body in a eukaryotic cell. It is called the 
control center of the cell since it controls many of the activities of the cell including cell 
reproduction. Contained within the nucleus are chromosomes which are microscopic, 
threadlike strands composed of DNA. Regions of the DNA are gene coding segments used 
by a cell to create cellular workers like proteins that control the function of a cell. The 
proteins are coded by the sequence of DNA which is written in the chemical letters A, T, 
C, and G. When proteins are needed, the information contained in the DNA is transcribed 
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into RNA. The RNA is first processed and then transported out of the nucleus. Outside the 
nucleus, the proteins are built based upon the code in the RNA. Fig. 1 shows the 
relationship between nucleosome, chromosome, genes, and DNA. 
 
Figure 1: The relationship among the nucleus, the chromosome, the gene and 
DNA [28] 
2.1 DNA 
 Deoxyribonucleic acid (DNA) is a long-term storage device of organisms to store 
genetic information. It enables the transmission of genetic material from one generation to 
the next by passing copies of DNA to the offspring. Stored information is read by working 
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cells to build molecules, such as protein and RNA. These molecules are used to control 
how an organism looks, behaves and reproduces. 
 DNA may be single or double stranded. A single stranded DNA molecule, 
called a polynucleotide, is a chain of small molecule nucleotides. Each nucleotide is made 
with three separate parts: a phosphate, sugar, and nitrogenous base (Fig. 2). 
 
 
Figure 2:  The basic unit of polynucleotide chain is the nucleotide 
I. Phosphate component: The phosphate group is a phosphorus atom surrounded by four 
oxygen atoms. When nucleotides are joined together to form a polynucleotide, a phosphate 
group is attached to the sugar molecule of adjacent nucleotide to form the sugar phosphate 
backbone.  
II. Sugar component: There are two different kinds of sugars found in a nucleotide: 
deoxyribose and ribose. In DNA the sugar component of the nucleotide is deoxyribose. 
III. Nitrogenous base: There are five different canonical nucleotide bases.  These bases 
are Adenine (A), Guanine (G), Cytosine (C), Thymine (T) and Uracil (U) (Fig. 3). DNA is 
composed of the four bases adenine, guanine, cytosine and thymine. These five bases can 
be put into two categories: purine and pyrimidine.  
Adenine and guanine are purines and have similar structure. Cytosine, thymine and 







In joining nucleotides together, the sugar part of one nucleotide connects up to the 
phosphate part of the next nucleotide to produce a polynucleotide (Fig. 4). 
 
Figure 3: Types of nitrogenous bases  
 
Figure 4: Adjacent nucleotides connect to form a DNA polynucleotide 
A polynucleotide can be any length and have any order. The end of the 
polynucleotide is marked either 5’ or 3' representing the location of the hydrogen bond. 
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DNA is usually written with 5' left and 3' right. Fig. 5 shows the semantic representation 
and sequence of a single strand DNA. 
 
Figure 5: Semantic representation and sequence of a single strand DNA 
 DNA is typically a double-stranded molecule, consisting of two complementary 
strands running in opposite directions. One chain runs 5'-3' and the other runs 3'- 5'. The 
two strands are connected to each other by hydrogen bonds pairing each base on one strand 
to a specific partner on the other strand. These complementary base pairs are adenine (A) 
- thymine (T), and guanine (G) - cytosine (C) (Fig. 6). Referring to the complementary 
base pairing mechanism, the second strand is known as the reverse complement of the first 
strand (Fig. 7). Complementary base pairing helps achieve direct synthesis of a 
complementary strand by using one strand of DNA as a template to copy the second strand. 
 




Figure 7: Semantic representation and sequence of complementary strands 
 Two complementary DNA strands are twisted to make a double helix structure 
(first discovered by Watson and Crick[29]). In the helix structure, the four nucleotides 
make up the stairs and strands run in opposite directions. 
 
Figure 8:  DNA double helix [30] 
2.2 RNA 
 Ribonucleic acid (RNA) is very similar to DNA; however a few important 
structural details are different. RNA is usually a single stranded molecule, while DNA is 
usually double stranded. RNA nucleotides contain ribose as the sugar component while 
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DNA nucleotides contain deoxyribose. Adenine, guanine, and cytosine are common bases 
for both RNA and DNA. But RNA uses the nucleotide uracil, instead of thymine. 
RNA plays a key role in the Central Dogma of Molecular Biology [31] which is a 
pathway from DNA to proteins. Three kinds of RNA molecules perform different but 
cooperative functions in protein synthesis. These are: 
I. Messenger RNA (mRNA): mRNA is a single strand RNA molecule used to transfer 
genetic information from DNA to ribosome via transcription. Because the information in 
DNA cannot be decoded directly into proteins, DNA is first encoded into mRNA during 
transcription.  
Transcription of DNA to mRNA is a two-step process. First, pre-mRNA is 
synthesized from one strand of a DNA using a complementary mechanism (Fig.9).  
       5'  A  G  C  G  G  T  C  A  A  T  3' 
DNA         |  |  |  |  |  |  |  |  |  |   
       3'  T  C  G  C  C  A  G  T  T  A  5' 
 
Pre-mRNA  5'  A  G  C  G  G  U  C  A  A  U  3' 
              
Figure 9:  DNA to pre-mRNA 
 Pre-mRNA contains both non-coding regions (introns) and coding regions 
(exons). Only exons are used to build proteins. Therefore, in the second step the introns are 
removed and the exons are spliced together to form mRNA (Fig.10). Later the formed 
mRNA is carried from the nucleus to the cytoplasm to be translated into a protein sequence. 
Take complementary of the second strand 
(T replaced by U because RNA has U) 
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 The amount of mRNA produced from DNA gives a measurement of the activity 
of individual genes in a cell, since only active genes are translated to mRNA. 
II. Ribosomal RNA (rRNA): Ribosomal RNA (rRNA) is a non-coding ribonucleic acid 
that is an essential and functional component of ribosomes. Ribosomes are small particles 
located in the cytoplasm (jelly like material that fills the cell). 
As non-coding RNA, rRNA itself is not translated into a protein, but provides a 
mechanism for translating mRNA into protein by interacting with the transfer RNAs during 
translation. 
 
Figure 10:  DNA to mRNA   
III. Transfer RNA (tRNA):  Transfer RNA (tRNA) is a specialized RNA that is produced 
by transcription like mRNA. tRNA functions in carrying amino acids to the ribosome to 
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form proteins. tRNA has a unique three-dimensional structure that helps to perform their 
function (Fig. 11). 
 
Figure 11: tRNA structure [32] 
Each tRNA molecule has an anticodon (three nucleotide sequence) and amino acid 
attachment site. The anticodon is unique for each amino acid which means that each tRNA 
binds a specific amino acid. During the translation of mRNA sequence to an amino acid 
chain (protein), the anticodon temporally pairs with a complementary consecutive triplet, 
the codon, in mRNA. At the same time the amino acid binds to tRNA by the help of 
enzymes. Subsequently the bound amino acid is transferred to the ribosome, where proteins 
are assembled according to the information carried by mRNA, and attached to the growing 
amino acid chain. 
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2.3 mRNA Structure 
 A processed mRNA consists of different regions as shown in Fig. 12. 
 
Figure 12: Mature mRNA 
2.3.1 Untranslated Regions (UTR) 
  UTRs are non-coding regions located on each side of a coding sequence on an 
mRNA. 
• 5 Prime UTR (5ꞌ UTR): The section of mRNA from the 5ꞌ end of the mRNA to just 
before the first codon used in translation. It functions as a transcriptional regulator [33].  
• 3 Prime UTR (3ꞌ UTR): The region on the mRNA from the 3ꞌ end of the mRNA. 3ꞌ 
UTRs affect the produced gene expression level by the mRNA. Prior to translation 
microRNAs can bind to the 3ꞌ UTR and reduce the gene expression level of mRNAs 
by marking it for degradation [34]. Silencer regions in the 3ꞌ UTR inhibit gene 
expression. In addition, proteins can bind to the adenylate-uridylate-rich elements (AU-
rich elements, AREs) located in the 3ꞌ UTR region and effect stability and degradation 
rate of transcripts. Moreover, poly(A) signals contained in the 3ꞌ UTR controls the 






2.3.2 Poly(A) Tail 
 When transcription of a gene terminates, a long chain of adenine bases called 
poly(A) tail is added to the 3ꞌ end of a messenger RNA [20].  It protects the mRNA 
molecule from enzymatic degradation, makes the mRNA more stable, and allows mRNA 
to be exported from the nucleus into the cytoplasm where it is translated into protein. 
2.4 Protein 
 Proteins are the biological molecules necessary for most of the activities in 
organisms including DNA replication, transportation of molecules and catalyzing 
biochemical reactions (enzymes) [35]. A protein molecule is made from long chain of 
amino acids. An amino acid is an organic compound which contains amine (NH2) and 
carboxylic acid (COOH) functional groups, along with a side-chain or R-group what makes 
each amino acid different from the others.  
 Proteins vary in their amino acid sequence which is encoded in the nucleic acid 
sequence of their gene. A protein is formed by a multiple step process (Fig. 13). A gene in 
DNA that carries the encoding of a specific protein is first transcribed into pre-messenger 
RNA (mRNA) via proteins such as RNA polymerase. Later pre-messenger RNA is 
processed to form mature mRNA and alternatively spliced to create different protein 
isoforms from a gene. The resulting mRNA is translated into protein by the process called 
translation. During translation, mRNA is read according to the genetic code. The genetic 
code is the set of rules for coding amino acids from three consecutive nucleotides called 




Figure 13: Simplified diagram of protein production from DNA 
 A protein folds into a specific three-dimensional structure defined by the amino 
acid sequence. The three dimensional structure determines the function of the protein since 
proteins function via physical interaction with other molecules [36].  
2.5 Chromosome 
 In a single human cell there are 46 chromosomes in DNA that makes 3 billion base 
pairs of DNA per cell. Because each base pair is around 0.34 nanometers long, each diploid 
cell contains about 2 meters of DNA. Moreover, an adult human body has about 50 trillion 
cells, which means there is 100 trillion meters of DNA per human. Since the sun is 150 
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billion meters away from earth, each human has enough DNA for more than 300 trips from 
the earth to the sun and back [37]. To fit long DNA strands into the microscopic space of 
a cell nucleus, DNA is packed into structures called chromosomes. The packing of DNA 
into a chromosome is done in several steps, starting with the double helix structure of DNA. 
Then, DNA is wrapped around proteins called histones. The resulting DNA protein 
complex is called chromatin. The fundamental packing unit of chromatin is the 
nucleosome. The nucleosome must be stable and tightly bound to compact DNA but at the 
same time must allow access to the DNA for the regulatory control to ensure correct gene 
expression. Eventually nucleosomes are folded and form chromosomes (Fig. 1). 
2.6 Gene 
 A gene is a continuous subpart of a single stranded DNA molecule. One strand of 
DNA contains many genes. All of these genes are needed to give instructions for how to 
build all of the proteins for an organism. Fig. 1 shows the relationship between a gene and 
DNA. 
2.7. Gene Regions 
 A gene consists of different regions and can be classified as protein coding genes 
or non-coding RNA genes. A nucleotide sequence in the gene may be in one of the 
following regions: 
2.7.1 Intron  
 An intron is a non-coding nucleic acid sequence region. It is located inside of a 
gene and the corresponding RNA transcript of most of the organisms. The amount and size 
of introns varies according to organism, gene and location of a gene in the cell. They are 
removed during alternative splicing and do not have an effect on the final product of the 
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gene. But it does not mean that they do not serve a purpose. After alternative splicing they 
may produce non-coding RNA molecules [38]. Furthermore, some introns encode specific 
proteins by themselves.  
2.7.2 Exon  
 An exon is a coding nucleic acid sequence part of a gene. It contains information 
for protein synthesis. After introns are removed, exons join together during alternative 
splicing and create mature mRNA.  
2.7.3 Open Reading Frame (ORF)  
 An open reading frame is the part of the reading frame that starts with start codon 
ATG (Met) and ends with one of the three stop codons (TAA, TAG, TGA). A reading 
frame is a sequence of nucleotide triplets (codons) which contains directions for making a 
protein. In a single strand of nucleic acid there are three possible reading frames, each 
beginning from a different nucleotide in a triplet. 
In double stranded DNA, an additional three possibilities come from the 
complementary sequence.  Gene prediction starts with an open reading frame search. 
2.7.4 Coding sequence (CDS) 
  CDS is a region of DNA that is known to be translated to a protein. It is also 
called the coding sequence. A CDS begins with start codon ATG next to the 5` end and 
terminates with one of the three stop codons (TAA, TAG, TGA) next to 3` end. The main 
difference of CDS from ORF is they are known to be transcribed into a protein, neither the 
gene nor the protein must be known but ORFs are potential protein coding regions and may 
also contain non-coding RNA. 
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                          5׀  … agtacgctgaatagcgtattttcatttgaggacgatgtataa … 3’  
Frame 1                      agt acg ctg aat agc ttt tca ttt gag gac gat gta taa 
Protein Sequence         S   T     L   N   S   F   S   F   E    D    D   V   * 
Frame 2                      gta cgc tga ata gcg tat ttt cat ttg agg acg atg tat 
Protein Sequence         V   R   *     I    A   Y  F   H  L    R    T   M   Y 
Frame 3                      tac gct gaa tag cgt att ttc att tga gga cga tgt 
Protein Sequence        Y   A    E   *     R   I   F   I    *    G    R   C 
The sample DNA sequence is showing 3 different reading frames in the forward 
direction. Open frame 1 starts with “a”, open frame 2 starts with “g”, open frame 3 
starts with “t” and “*” indicates the stop codons.  Each frame line followed by 
translated amino acid sequence. The possible longest ORF is in open frame 1. 
 Figure 14: Possible open reading frames from a DNA sequence    
2.8 Gene Expression 
 Almost every cell in an organism contains a complete set of genes but each gene 
in the set is not used by a specific cell due to the effect of cell type, cell development and 
environmental changes. This important mechanism of cells relates the importance of 
differential gene expression.  
 The separation of active and inactive genes is carried out by a process known as 
gene regulation. When a gene is turned on, the molecular product of this gene can be 
synthesized, and subsequently identified as expressed. Oppositely when a gene is turned 
off, the molecular product of this gene cannot be synthesized and the gene is identified as 
unexpressed. 
 Gene expression analyses reveals the function of genes, cell-cell differences, cell 
interactions and where, when and in which conditions a gene expressed. The expression 
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analyses of many genes can be determined by measuring mRNA levels with multiple 
techniques including in situ hybridization and microarrays. 
2.9 Central Dogma of Molecular Biology 
 In 1958, Francis Crick used the term “Central Dogma” for the idea of one-way 
genetic information flow between macromolecules and he explained it as “once 
‘information’ has passed into protein it cannot get out again. In more detail, the transfer of 
information from nucleic acid to nucleic acid or from nucleic acid to protein may be 
possible, but transfer from protein to protein, or from protein to nucleic acid is impossible” 
[31]. 
 In the Central Dogma there are three major classes of macromolecules: DNA, RNA 
(both nucleic acids) and proteins [39]. By using the three macromolecules, nine 
information transforms are defined and classified into three groups: general, special and 
unknown transfers. The general transfers are: DNADNA, DNARNA and 
RNAProtein transforms. They usually occur in most cells. The special transfers are: 
DNAProtein, RNADNA and RNARNA. They only occur in a laboratory or in the 
case of some viruses under specific conditions. The unknown transfers are: ProteinDNA, 
ProteinRNA and ProteinProtein. Fig. 15 is taken from original work of Francis Crick 




Figure 15: Central Dogma of Molecular Biology [40] 
2.9.1 General Transfers 
a) DNA replication 
 DNA replication is the process that a cell uses to copy DNA with the help of 
enzymes and proteins. In order to start DNA replication, the double stranded DNA helix 
must be opened. Helicases and single strand DNA binding proteins unwind the DNA into 
two single strands. After that, DNA polymerase III, I, ligase and primase proteins work 
together to build copies of template DNA (Fig 16). 
b) Transcription 
The process of creating a complementary RNA from a DNA template is called 
transcription (Fig. 17). In protein coding regions, the resulting complementary RNA copy 
is called mRNA. mRNA naturally exists in single stranded forms and acts as a template for 
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protein synthesis. The enzyme called RNA polymerase transcribes DNA to mRNA. After 
transcription, mRNA is moved to the ribosome where it is translated into protein. 
 
Figure 16: DNA replication [41]  
Transcription has main three steps: 
I. Initiation: DNA is transcribed by the enzyme RNA polymerase. In this step RNA 
polymerase attaches to the DNA at a specific area called the promoter region by using 
specific nucleotides sequences. Promoters are the regions of the DNA that signal initiation 
of transcript.  
II Chain elongation: RNA polymerase moves along the one strand of the DNA, the 
template strand, and creates mRNA.  
III. Termination: When the RNA polymerase reaches the termination sequence, it releases 
the mRNA and detaches from the DNA. 
c) Translation 
 Translation is the part of protein synthesis that produces a specific amino acid chain 
by decoding the mRNA generated by transcription (Fig. 18). It is performed by the 




Figure 17: Transcription [42] 
Translation has main four steps: 
I. Activation: Amino acids are attached to the tRNA. 
II. Initiation: mRNA binds to the small subunit of the ribosome and the ribosome moves 
along the mRNA until it reads the start codon AUG. At that point in time, the large subunit 
of the ribosome attaches to allow starting of translation and start codon AUG binds with 
the tRNA that has anticodon UAC and the bound amino acid methionine. 
III. Elongation: In elongation another tRNA attaches to the ribosome next to the start 
codon and binds a new amino acid to the first one to form polypeptide chain. The binding 
process repeats until a full polypeptide chain is formed according to the sequence of bases 
in the mRNA. 
IV. Termination: When the ribosome reads a stop codon (UAA, UAG, UGA) on the 
mRNA, the completed protein is released from the final tRNA then the last tRNA and the 




Figure 18: Translation [43] 
2.9.2 Special Transfers 
a) Reverse transcription 
 The transfer of information from RNA to DNA is reverse transcription. It occurs in 
retroviruses (RNA virus), such as HIV or retrotransposons (amplifying the genetic 
elements) and telomere (a region of repetitive DNA sequence at the end of a chromosome) 
synthesis.  
b) RNA replication 
 Producing a new RNA from RNA is RNA replication. It is used to reproduce some 
viruses. These viruses can be double-stranded or single-stranded RNA [44]. Double-
stranded RNA viruses make single-stranded RNA molecules from the double-stranded 
RNA molecules. Single-stranded RNA viruses are divided into two groups: negative-sense 
single-stranded RNA viruses and positive-sensed single-stranded RNA viruses. The RNA 
molecule of negative-sense viruses cannot be read directly to create proteins. First, 
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complementary RNA is created and used to produce viral proteins. RNA molecules of 
positive-sensed single stranded RNA viruses can be read directly for the synthesis of viral 
proteins. 
c) Direct translation from DNA to Protein 
 Translation of proteins directly from DNA has been shown in cell-free systems. 
DNA is obtained from mammalian cells and added into an Escherichia coli cell-free 
system. Later antibiotics are added to the system and protein is produced directly from 
single stranded DNA [45].  
2.10 Genetic Code 
When the information is needed to make a protein, one strand of a DNA molecule 
is transcribed to mRNA. Later the mRNA is translated to a protein composed of amino acid 
molecules. Since there are only four bases in mRNA to code the 20 amino acids, more than 
one base must be used to specify an amino acid. Even using two bases to code all 20 amino 
acids is not enough (4x4 = 16). Therefore, three bases are required to decode one amino 
acid. A single set of these three bases is called a codon and the set of all possible 
combinations of three bases called the genetic code first discovered by Marshall Warren 
Nirenberg [46] in 1968 (Table 4). There are 64 (4x4x4) different combinations or codons. 
Three of them are stop codons which gives a signal to terminate the amino acid chain being 
synthesized on the ribosome. The start codon is AUG. It also encodes the amino acid 






TABLE 4: Genetic code 
 
The following is an example to show how codons decoded from mRNA to amino 
acid chain. “*” denotes stop codons and the sequence is partial, where it assumes that the 
start codon already passed. 
DNA:  UUA ACA UGA AAG AUG ACA UAC GAU AGC GAU GAU CGA CGC  
              Leu   Thr     *      Lys    Met   Thr    Tyr   Asp   Ser    Asp   Asp    Arg   Arg 
                L       T       *       K       M      T       Y      D      S       D       D        R       R 
2.11 Alternative Splicing 
 Alternative splicing is a process which increases the biodiversity of proteins by 
allowing multiple proteins to be created from one section of a DNA. It is also called 
differential splicing.  
 A gene is first transcribed into a pre-messenger RNA which is a copy of a specific 
section of DNA containing both introns and exons. After introns are removed from pre-
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mRNA, exons join together by the alternative splicing process. During alternative splicing, 
exons of a gene can be spliced together in different ways to create different mRNAs from 
that gene. As a result, the proteins coded by alternatively spliced mRNAs contain different 
amino acid sequences and often function differently.  
 Alternative splicing events can be categorized into five main types: 
• Exon skipping: An exon of a gene can be excluded from the produced mRNA. 
• Intron retention: An intron can remain in the produced mRNA. 
• Mutually exclusive exons: One of two exons is included in the produced mRNA, not 
both. 
• Alternative donor site: An alternative 5ꞌ splice junction is used.  
• Alternative acceptor site: An alternative 3ꞌ splice junction is used. 
 






 A single gene can produce multiple proteins by using alternative splicing to create 
different transcripts. As a result, transcripts of the same gene differ in the exons used to 
construct the corresponding mRNA. For example, table 5 provides the transcript list of the 
gene CTLA4 and the proteins that transcripts produce. From the CTLA4 gene, a cell can 
have five different transcripts and produce four different proteins.  
TABLE 5: Transcripts of the Gene CTLA4 
Name Ensembl Transcript ID Protein 
CTLA4-001 ENST00000302823 223aa 
CTLA4-005 ENST00000295854 174aa 
CTLA4-002  ENST00000427473 
 
137aa 
CTLA4-004 ENST00000472206 79aa 




2.13 Noncoding DNA 
 Noncoding DNA is the region of DNA that does not contain protein coding 
information [47]. Although initially these regions were thought to be non-functional and 
therefore called junk DNA, noncoding DNA does have important functions in the genome 
such as they control when, where and what level gene expressed via promoters, enhancer 
and silencer regions. These regions may also produce non-coding RNAs (miRNAs, 
lncRNAs, sncRNAs, …) The proportion of the noncoding DNA within organisms varies. 
For example, in the human genome 98% or more of the genome is noncoding, whereas in 





  Promoters are adjacent to a gene near the 5`end of the transcription initiation 
site. They indicate the start point of gene transcription and provide a binding site for RNA 
polymerase. RNA polymerase initializes the transcription by binding to the promoter 
sequence. Many eukaryotic genes have an A-T rich promoter sequence called a TATA box. 
This name comes from the preserved sequence most commonly observed TATAAA. 
During transcription a TATA binding protein binds to the TATA-box to unwind DNA and 
the bend it through 80o.About 24% of human gene have TATA-box.  
2.13.2 Enhancer 
 Enhancers are DNA sequences that increase the expression of a specific gene 
when bound by transcription factor proteins (activator) [48]. Enhancer sequences can be 
located in both forward and backward direction. They can be located in the intron of the 
gene being regulated or up to one millions of base pairs away from the gene. The long 
distance between the enhancer and the gene does not affect the function of enhancers 
because of the folded and coiled chromosome structure of DNA. Spatially they can be 
located near the transcription start site in chromosome structure.  
2.13.3 Silencers 
 Silencers are DNA sequences that block the expression of a specific gene when 
bound by proteins (repressor) [49]. They are mostly located in the upstream of the targeted 
gene. The distance ranges from 20 base pairs to 200 base pairs upstream of a gene. Some 






 Curiosity concerning the building blocks of life has led to the development of 
technologies that have had huge impact on the fields. In the 1970’s Edward M. Southern 
developed the technique of Southern blotting to locate particular gene or DNA sample in 
the genome via gel electrophoresis and probe hybridization [50]. In 1977 Frederick Sanger 
developed the Sanger sequencing method to determine the sequence of DNA by a chain 
termination technique based on the use of dideoxynucleotides in addition to the normal 
nucleotides found in DNA [51]. In the same year, James Alwine and George Stark 
developed the northern blotting technique to detect specific mRNA in a sample [52]. In 
1983 Kary Mullis developed the polymerase chain reaction (PCR) technique to allow 
exponential amplification of DNA segments (thousands to millions of copies of a particular 
DNA sequence) [53]. Shortly after, PCR became a fundamental technique used in many 
medical and biological laboratory protocols. In terms of gene level analysis, researchers 
were using all these methods to work on one specific gene product per experiment. In 1995 
Schena et al. published the first paper about DNA microarray technology which allows 
parallel analysis and investigation of thousands gene products using known sequence data 
that is complementary to the gene of interest [54]. More recent advances allow scientists 




3.1 DNA Microarray  
  A DNA microarray (DNA chip or biochip) is a technology used to identify and 
measure the level of mRNA present in prokaryotic and eukaryotic DNA. It is a solid surface 
usually a glass, microscope slide or a silicon chip with fixed locations called cells, spots or 
features [55]. The spots contain millions of identical selected oligonucleotides called 
probes (Fig. 20).  
 
Figure 20: Microarray features and probes 
 Each probe corresponds to a fragment of genomic DNA, cDNAs, PCR products or 
chemically synthesized oligonucleotides of up to 800 bases. These oligonucleotides are 
complementary to a gene of interest such as transcripts or exons. In microarrays, one or 
more oligonucleotides group together and represent a gene of interest. Some microarray 
platforms use microscopic beads in place of solid surfaces.  
Microarrays have been used to identify relative gene expression to learn about cell 
functions, cell differentiation, genotyping, single nucleotide polymorphisms (SNPs), effect 
of treatment over diseases, changes of a particular gene involved in a disease and 





Nucleic acid hybridization is the basis of microarrays [56]. It is the process in which 
similar single stranded nucleic acid sequences interact and form hydrogen bonds between 
complementary bases adenine (A) - thymine (T) and guanine (G) - cytosine (C). It can 
happen between DNA/DNA, RNA/RNA, DNA/RNA and short oligonucleotides. 
Through nucleic acid hybridization, the degree of similarity between two nucleic 
acid strands can be measured and the complementary sequences of interest (targets) can be 
identified. In a microarray experiment, hybridization happens between probes and 
complementary target mRNAs which were obtained from test samples. 
3.1.2 DNA Microarray Experiment 
A microarray experiment starts with sample extraction from two different subject 
cells to be compared such as treated-untreated, healthy-diseased, and mutant-wild type. 
Subsequently samples are labeled. The resulting labeled samples are called targets. Once 
samples are prepared they are diffused over the microarray. There are two major types of 
DNA microarrays: one-color and two-color. When one-color microarray is used, samples 
are labeled with a single dye (such as phycoerythrin, cyanine-3 (Cy3), cyanine-5 (Cy5) or 
biotin) and hybridized to separate microarrays. When two-color microarrays are used, 
samples are labeled with two different fluorescent dyes and hybridized together on a single 
microarray. To remove unbound targets, the array is washed after hybridization.  
  One-color microarrays are also called single-channel microarrays. Since only a 
single dye is used and each sample hybridized to different microarrays, the obtained data 
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gives the estimation of absolute value of each gene’s expression for each sample. Some of 
the benefits of using one-color system are:  
• Comparing the absolute values of gene expression between different experiments 
is easier even when the experiments are done in different times and locations. 
• An abnormal sample cannot affect the other samples’ raw data because each sample 
is hybridized to a separate microarray. 
• When the experiment becomes more complicated such as effect of treatment over 
time, one-color microarray is usually advisable. 
 
Figure 21: One-color Affymetrix® GeneChips® microarray experiment diagram 
 In a two-color microarray, samples hybridize on the same microarray therefore it 
estimates the gene expression concentration ratios (each gene up or down regulated). Fig. 
 39 
 
22 shows a schematic for a two-color microarray experiment that is designed to compare 
experimental sample (cancer cell) representing the expression pattern of genes in a specific 
set of conditions with a control sample (normal cell) representing all the genes that are 
expressed in the cells to be analyzed. 
 
Figure 22: A typical two-color microarray experiment diagram 
Multiple steps are involved in a two color microarray experiment. 
1. Each experiment starts with isolation of mRNAs that represent the amount of genes 
expressed at the time of sample collection from the experimental sample. For example, 
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cancer cells and a control sample (normal cells). The success of the experiment depends 
on the quality of the extracted mRNAs. 
2. Next, the extracted mRNAs are converted into complementary DNA (cDNA) with the 
help of a reverse-transcriptase enzyme and labeled with a different fluorescent cyanine 
dyes (Cy3 and Cy5) to track the cDNAs coming from different samples. 
3. The labeled experiment and control cDNA are mixed together, and then purified. After 
purification, the mixed labeled cDNA is hybridized to microarray. The microarray is 
washed to remove any labeled cDNA that did not hybridize on the microarray and 
heated to reduce cross hybridization. Each labeled cDNA only binds to its 
complementary target sequence on the microarray. 
4. In the final step, an image of the microarray surface is produced by scanning to 
determine how many labeled cDNA probes bound to target spots in the microarray. In 
this experiment, red spots on the microarray represent genes upregulated compared to 
normal samples, green spots represent genes that are downregulated in the cancer 
sample, and yellow spots represents genes that active in both cancer and normal 
samples. The upregulated and downregulated genes can be further investigated with 
data mining techniques such as clustering. 
 In two-color microarray experiments dye bias may affect the identification of 
differentially expressed (up-regulated) genes and increase the false positive and negative 
results. The most common approach to correct dye bias is dye swap design. In dye swap 
design, the initial experiment and control samples are labeled with Cy3 and Cy5 and then 
hybridized on a chip. Later on, the process is repeated by switching the dyes of the two 
 41 
 
samples. The results of two samples are averaged and used to identify differentially 
expressed genes. 
3.1.3 Experimental Variations in Microarray Platforms 
 The purpose of a microarray experiment is measuring changes of mRNA levels 
between different state of interests such as cancer cell versus non-cancer cell to detect 
significant changes between states by applying analysis algorithms. But a detected 
significant change may not always be real. The significant change might be result of a 
random change, systematic bias in the biology, study, or samples [57] which is explained 
by computer science originated principal “garbage in, garbage out” that the quality of the 
analysis output received from a biological experiment depends on the quality of the 
experimental data. Thus, it is important to make sure that steps taken during the microarray 
experiment do not introduce deviations over the mRNA changes originated by the state 
changes of interests [58]. For example, biologist must make sure samples are not 
contaminated, and signals are not coming from other forms of RNAs included in the 
samples addition to mRNAs of actual interest of samples. This can be performed by 
biologist having control over all stages of experiments and analysis, using replicates and 
cooperating their biological knowledge with the data they are studying via microarrays. 
They can use mean, median standard deviations values to detect outliers, scatter plots and 
histograms to observe what is accruing in a microarray.  
3.1.4 Types of the DNA Microarrays Based on Technology 
 Microarray fabrication varies based on the probe type, solid surface used, probe 




Printed Microarrays: In the first microarrays chemically, synthesized oligonucleotides 
were printed or spotted onto very fine solid surface usually a glass via either noncontact or 
contact printing. In noncontact printing, the probe liquid droplets are applied onto 
microarray surface by the same technology used for computer printers. In contact printing, 
print pins are used to apply probes directly into a specific spot on the surface. Probes in 
printed microarrays are either double-stranded DNA (dsDNA) or oligonucleotide. dsDNAs 
range from 200 to 800 bases. Oligonucleotides range from 25 to 80 bases.  
In Situ-Synthesized Oligonucleotide Microarrays: In situ-synthesized arrays are high-
density DNA microarrays. The solid surface used for in situ-synthesized microarrays is 
typically a quartz wafer or glass. Probes in the arrays are chosen from oligonucleotides. 
Oligonucleotides are directly synthesized on the microarray surface. The manufactured in-
situ-synthesized microarrays are Agilent, Roche NimbleGen and Affymetrix® 
GeneChips®. Agilent uses a non-contact industrial inkjet printing process to spot 
oligonucleotides onto specially-prepared glass slides. Agilent probe length is 60 bases and 
most genes represented by single probe rarely by couple of probes. Agilent technology 
places all four nucleosides simultaneously onto glass slide in repeated cycles of base by 
base printing, requiring only one synthesis cycle per layer which leads to having longer 
and more specific probes. Roche NimbleGen uses maskless photo-mediated synthesis. 
Probe length ranges from 60 to 100 bases. Currently Roche NimleGen arrays are not 
available. Both Agilent and Roche NimbleGen allow multicolor experiment.  
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 Alternative to Agilent and Roche NimbleGen arrays is Affymetrix® GeneChips® 
which is the most widely used array. Affymetrix® GeneChips® use semiconductor-based 
photolithography to construct individual probes of length 25 bases. Different than Agilent, 
multiple probes represent a gene. Affymetrix® develops and commercializes variety of 
arrays for plants, animals and microorganisms. In addition to predesigned arrays, they 
provide MyGeneChipTM service where researchers can design their own arrays for 
specialized studies. Data formats used by Affymetrix® are very well standardized. They 
also provide necessary experiment reagents, tools and software to obtain and analyze the 
results. Affymetrix GeneChips® are limited to one color based on a biotin labeling. 
3.2 Affymetrix® GeneChips®  
 Affymetrix® GeneChips® are the most commonly used prefabricated arrays for 
gene expression analysis. In Affymetrix® GeneChips® 11-20 probes, each of them 25 
nucleotides length, form a probe set and represent transcript variants of a gene. Probes are 
chosen from the region of a gene that has the least similar nucleotide sequence to other 
genes [56] and placed onto a silica wafer substrate via a photolithography technique as 
probe pairs (Fig. 23). Each probe pair has one perfect match (PM) probe and one 
mismatched probe (MM). In the most recent Affymetrix® GeneChips®, the MM probes 




Figure 23: Affymetrix® GeneChips® microarray design 
PM probes have an exact complementary sequence to the transcript of a gene based 
on a reference genome (Fig. 24). Each MM probe differs from the perfect match probe by 
a complementary base located in the middle of a probe sequence (13th base). PM probes 
help to measure the expression level of gene transcripts, while MM probes help to inspect 
PM probe and detect cross hybridization events and background signals.   
 
Figure 24: Affymetrix® GeneChips® probe selection and perfect match (PM), mismatch 
(MM) probe sets                                                                                                                                                                  
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3.2.1 Array Design 
The successful Affymetrix® GeneChip® array design requires selection of unique 
multiple probes for each transcript. Affymetrix® GeneChip® probe set design involves 
collecting sequences, annotating sequences via clustering, selecting a single sequence that 
represents the cluster and tiling this sequence into 25 base probes. 
Probes are selected from consensus or exemplar sequences. The strategy for probe 
selection regions varies according to the purpose of the array. Some arrays may examine 
the gene expression in the level of exons and isoforms others may focus on polyadenylation 
sites. In the HG-U133 arrays more than one probe selection regions were selected in order 
to cover alternative polyadenylation sites. To decide the probe selection regions, potential 
transcript ends were identified by any of the following criteria (Fig. 25): 
• The 3ꞌ end of a potential full length member sequence (RefSeq and complete CDS 
mRNA sequences). 
• A set of eight or more ESTs ending at the same position. 
• 3ꞌ end of the consensus sequence, a sequence obtained from the sequence of the 
cluster members. 
Later on, probes were selected from the 600 bases most nearest to the 3ꞌ end of exemplar 
or consensus sequence (Fig. 25). In the case of selecting probes within the putative 
transcript ends, the exemplar mRNA sequence is used. For all other transcript ends the 
consensus sequence is used. When the orientation of cluster is unknown or uncertain the 




Figure 25: Affymetrix® GeneChips® Human Genome U133 multiple probe selection 
regions (Figure adopted from Array Design for the 
GeneChip® Human Genome U133 set technical note [60] ) 
                                                                                                                                                                  
 
Figure 26: GeneChips® Human Genome U133 arrays transcript, consensus sequence, 
and probes relationship 
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 In the human Exon 1.0 arrays probes were selected from exons of the consensus 
sequence (Fig. 26).                                                                                                                                                                      
Due to multiple potential probe selection regions, some heuristic rules are applied 
to give priority for well annotated and strongly supported regions so they can be presented 
in the array. The regions represent the mRNAs, annotated as containing the complete 
coding sequence and 3′ untranslated sequences. Evidence of polyadenylation, the size of 
cluster, orientation and genomic mapping were used for EST-only clusters prioritization 
decisions.  
The heuristic probe selection strategies were intended to select probes unique to a 
single transcript or common among a small set of transcripts variants, but the hybridization 
characteristic of probes was not considered. With the designed technique for HG-U133, 
the probe binding characteristic was examined with multiple linear regression models 
based on a nucleic acid duplex formation thermodynamic model. The technique predicts 
the probe binding affinity and linearity according to the varying target concentrations.  
After probes were selected, they were grouped together to form a probe set. The 
HG-U133 set contains 11 probe pairs per probe set. The older version has 16-20 probes per 
probe set. In human genome U133 Plus 2.0 arrays, the probe set names were marked via 
suffixes (Fig. 27). If all probes were perfectly matched to transcripts of same gene, they 
were suffixed with “_a”. If all probes were perfectly matched to multiple transcripts of 
different genes, they were suffixed with “_s”. If probes were highly similar or identical to 
other sequences, they were suffixed with “_x”. The probe sets with probes match to single 




Figure 27: GeneChips® Human Genome U133 Plus-2 probe set marking (Figure adopted 
from Design and Performance of the GeneChip® Human Genome U133 Plus 2.0 and 
Human Genome U133A 2.0 Arrays technical note [61] ) 
3.2.2 Attaching Probes 
 Affymetrix® uses a photolithography technique to attach probes into spots. It is a 
similar technique used for silicon computer chips where removal and positioning of silicon 
material on the chip is controlled by selectively exposing light with the help of a mask. 
Affymetrix® GeneChip® arrays photochemically modified synthetic linkers attached to 
the array surface to block the nucleic acid addition until deprotected by a light. Ultraviolet 
light is exposed to the array through the mask. Each mask is produced with windows that 
direct the order of nucleotide addition by either transmitting or blocking the ultraviolet 
light. When the mask has an open window at a specific spot, the spot gets deprotected and 






3.3 Data Files 
3.3.1 Affymetrix GeneChip® Data Files  
 Affymetrix® GeneChip® technology uses special data formats to store GeneChip® 
array information and the experimental results [62]. In this research, we obtained the 
performed experimental results as CEL files and modify the original Chip Description Files 
(CDFs) to create custom CDFs according to the current genomic data.  
 
Figure 28:  Affymetrix GeneChip microarray probe attaching via masked 
photolithography (Figure adopted from Basic Concepts of Microarrays and Potential 
Applications in Clinical Microbiology [59]) 
Some of the important files are: 
a) EXP File: The EXP file contains information about experimental conditions and 
protocols. It has three sections: sample information (chip type, sample type, operator), 




b) DAT File: The DAT file contains the pixel intensity values of the image produced by 
the Affymetrix® scanner. It is a binary file and contains two sections: header and pixel 
intensity data. It starts with header section and followed by pixel intensity data section. 
Header has the dimension of the image (pixel number, coordinates of the grid, number 
of rows etc.), the scanning conditions (temperature, scan speed, laser power, etc.) and 
intensity related values (mean pixel value, minimum and maximum pixel value etc.) 
The pixel intensity data has the intensity values of each row stored as 16-bit unsigned 
integer values.  
 
Figure 29:  Part of the ASCII EXP file of chicken genome array supplied by Affymetrix® 
in the Sample Data for GeneChip® Arrays 
c) CEL File: The CEL file contains the calculated intensity values of each probe based 
on the pixel intensities stored in a DAT file. It also provides the standard deviation of 
intensities, the number of pixels used for the intensity calculation, an outlier flag and a 
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user defined flag to indicate the spots that need to be left out during the analysis. It can 
be either in ASCII text format (Version 3) or in binary format (version 4).  
d) Chip Description Files (CDF): The CDF file stores the layout information for an 
Affymetrix® GeneChip® array. Some of the important data described in CDF are: 
which probes belong to which probe set, spot coordinates of each probe, name of probe 
sets and PM-MM probe pairs (Fig. 31). It is used to read the intensity values of probe 
sets located in the CEL file to detect the expression level of genes or transcript variants 
of a gene. There are two versions of each CDF: an ASCII text format and XDA format. 
 
Figure 30:  Part of the ASCII CEL file of chicken genome array supplied by Affymetrix® 




Figure 31: Part of the ASCII HG-U133_Plus_2.cdf file 
e) The Gene Information (GIN) File: The GIN file contains genomic information of a 
specific array such as the gene names associated with each probe set.  
 
Figure 32: Part of the ASCII HG-U133_Plus_2.gin file 
f) Probe Set Information (PSI) Files: Probe set names and the number of probe pairs in 
a probe set. It uses ASCII text format. The first line of the file has the number of probe 
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set names with “#Probe Sets” tag, the rest of the file contains the probe set names and 
number of probe pairs in the probe set.  
 
Figure 33: Part of the ASCII HG-U133_Plus_2.PSI file 
3.3.2 FASTA File Format 
 FASTA format is used to describe nucleotide or peptide sequences in a text-based 
file [63]. A sequence in FASTA format has two parts: single line description and sequence 
data (Fig. 34). The description line starts with a greater-than (>) symbol. The word 
following > is the identifier of the sequence, and the rest of the description line is optional. 
The sequence data has the nucleotides or amino acids represented by single-letter codes. 
Simple FASTA structure makes parsing easier for text-processing programs. 
>probe:HG-U133_Plus_2:1007_s_at:718:317; Interrogation_Position=3330; Antisense; 
CACCCAGCTGGTCCTGTGGATGGGA 
>probe:HG-U133_Plus_2:1007_s_at:1105:483; Interrogation_Position=3443; Antisense; 
GCCCCACTGGACAACACTGATTCCT 
>probe:HG-U133_Plus_2:1007_s_at:584:901; Interrogation_Position=3512; Antisense; 
TGGACCCCACTGGCTGAGAATCTGG 
>probe:HG-U133_Plus_2:1007_s_at:192:205; Interrogation_Position=3563; Antisense; 
AAATGTTTCCTTGTGCCTGCTCCTG 
>probe:HG-U133_Plus_2:1007_s_at:844:979; Interrogation_Position=3570; Antisense; 
TCCTTGTGCCTGCTCCTGTACTTGT 
Figure 34: A part of the Affymetrix® GeneChip® HG-133 Plus 2 FASTA file  
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3.3.3 General/Gene Transfer Format 
 General/Gene Transfer Format (GTF) is a tab-delimited text based file format 
which is used to represent a gene structure information. GTF is an extended version of the 
general feature format (GFF). It has additional columns specific to gene information. The 
columns in a GTF are: 
• seqname : Name of the sequence usually chromosome, contig or scaffold id.  
• source : Name of a data source. It can be a program name, project name etc. 
• feature : Feature type name: Gene, transcript, exon, start_codon, stop_codon, CDS.  
• start : Start position of the feature. 
• end : End position of the feature. 
• score : A confidence degree in the feature existence and coordinates. 
• strand : Direction of the feature + is for forward, - is for reverse. 
• frame : 0, 1 or 2. 0 means that feature begins with whole codon, 1 means that before 
the first whole codon, there is one extra base, 2 means that there are two extra bases 
before the first whole codon.   
• attributes : Semicolon separated additional information about a feature. 
• comments : Comments begin with hash (#).  
 The following is an example gene structure with nine exons and two transcripts 







1 havana gene 11869 14409 . + . gene_id "ENSG00000223972";  
1 havana transcript 11869 14409 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id 
"ENST00000456328";... 
1 havana exon 11869 12227 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id 
"ENST00000456328";... 
1 havana exon 12613 12721 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id 
"ENST00000456328";...; exon_id "ENSE00003582793";  
1 havana exon 13221 14409 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id 
"ENST00000456328";...; exon_id "ENSE00002312635"; exon_version "1"; 
1 havana transcript 12010 13670 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id 
"ENST00000450305";...  
1 havana exon 12010 12057 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id 
"ENST00000450305"; ...; exon_id "ENSE00001948541"; exon_version "1"; 
1 havana exon 12179 12227 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id 
"ENST00000450305"; ...; exon_id "ENSE00001671638"; exon_version "2"; 
1 havana exon 12613 12697 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id 
"ENST00000450305";...; exon_id "ENSE00001758273"; exon_version "2"; 
1 havana exon 12975 13052 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id 
"ENST00000450305";...; exon_id "ENSE00001799933"; exon_version "2"; 
1 havana exon 13221 13374 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id 
"ENST00000450305";...; exon_id "ENSE00001746346"; exon_version "2"; 
1 havana exon 13453 13670 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id 
"ENST00000450305";...; exon_id "ENSE00001863096"; exon_version "1"; 




CUSTOM CHIP DESCRIPTION FILES (CDF) 
 In Affymetrix® GeneChip® technologies, probe sets are formed from eleven to 
twenty short oligonucleotide sequences called probes (see Section 3.2). After the 
hybridization of specific samples is performed with an Affymetrix® GeneChip®, the 
obtained intensity level of a probe set is interpreted as a gene expression level of the 
specific gene. Therefore, more accurate selection of probes leads to more accurate 
biological interpretation of experimental results. 
 Given a particular Affymetrix® GeneChip® platform, the design of the probes is 
fixed. However, the methods in which the resulting experiments can be analyzed are 
dynamic in nature due to the ability to annotate and group probes into uniquely defined 
groupings. This is particularly important given that there are 97,015 data series publicly 
available in the GEO [64] repository as of April, 2018. 4,873 data series sharing the exact 
same chip design which is Affymetrix® GeneChip® Human Genome U133 Plus 2.0. Each 
dataset consists of reassembled original submitter supplied records and curated data for 
biologically comparable samples. One way in which the analysis can dynamically change 
is by correcting the mapping between probe sets and genes by creating custom CDFs (Chip 
Description File) to arrange which probes belong to which probe set based on the latest 
genomic information or specific annotations of interest. Each analysis can improve the    
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results of the microarray experiment or make them more relevant to annotations specific to 
particular analysis. 
 This chapter mainly focuses on the issues of microarrays and previously suggested 
solutions to address these issues. 
4.1 Limitations of Microarrays 
 Since GeneChip® designs are by their nature fixed, the selection of probes relied 
on earlier genome assemblies and annotation available at that time. Due to rapid progress 
of genome sequencing and annotation, significant differences can arise between the earlier 
and the current genome databases. The current databases are likely to be more accurate 
than the earlier ones, contain more annotated coding and non-coding genes, and reveal 
more information about alternative splicing of genes. Table 6 shows the original sequence 
numbers of some source databases used for Human U133 Plus 2.0 Affymetrix® 
GeneChip® at the time it was created and the latest ones. It is obvious there are significant 
differences that should be taken into account, making it necessary to update probe-gene 
mapping according to current databases. Affymetrix® does attempt to provide 
compatibility between genomic chances by updating the links between probe sets and their 
corresponding genes via NetAffxTM (http://www.affymetrix.com) [65]. NetAffxTM derives 
the functional and descriptive annotations of representative sequence from current releases 
of the UniGene [66], LocusLink [67] and Homologene [68] databases [69]. Representative 
sequence stands for the sequence that was represented by a probe set in the array. When a 
representative sequence could not be found in the databases, another representative 
sequence is assigned to probe set based on the originally assigned UniGene [66] cluster. 
But NetAffxTM does not provide a solution for problems caused by individual probes. 
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TABLE 6: The release date and the number of human sequences for UniGene, dbEST, 
Ensembl and RefSeq at the time of Affymetrix® HG-U133 design and the current versions 
 Original version Latest Version 
 Release Date Human Sequences Release Date Human 
Sequences 
UniGene April 20, 2001(#133) 2.688.626 March 9, 2013(#236) 7,000,789 
dbEST April 28, 2001 3.471.886 Jan 1, 2013(#130101) 8704,790 
Ensembl July 2001(#1) NA Apr 5, 2018(92)  3,609,003,417 
 
RefSeq April 2001 12.716 Mar 13, 2018(87) NA 
 
Potential issues with probes in a probe set are: 
I. Probes in a probe set that no longer align to a genomic location. In the HG-U133 Plus 
2 array a total of 40,680 probes out of 603,158 (excluding quality control probes) do 
not have a perfect match to the human genome assembly 38. 
II. Probes in a probe set might not match any transcribed sequence or might be targeting 
different genes than the designated gene of a probe set. Table 7 illustrates these two 
types of problems. In the original Human U133 Plus 2 Affymetrix® GeneChip® probe 
228543_AT has 22 probes, but only 11 of them match the RefSeq [70] entry 
NM_001164811. The rest of the probes do not match any RefSeq location. Probe 
228544_S_AT was originally created to measure expression level of the gene 
CSRP2BP. But half of its probes map to the PET117 gene. Both CSRP2BP and PET117 
are located in the chromosome 20 of forward strand and 5,051 bases of their sequence 
overlaps. If one uses this probe to measure expression level of CSRP2BP, it could 
reflect a cross hybridization with PET117. Probe 228543_AT has an even worse 
situation. Only one probe matches to CSRP2BP, 11 of them match to PET117 and 10 
of them do not match to any transcribed sequence. The expression level measured by 
probe 228543_AT does not reflect the integrated expression of the designated gene and 
therefore causes misinterpretation in quantification. 
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III. Multiple probe sets often represent a gene. Often those probe sets might be coming 
from the same splice variant or different splice variants. As long as probes were not 
marked with an id specific to one splice variant, the expression level of probes cannot 
be used as an indicator for the specific splice variant. In Table 7, both probe 
225432_S_AT and 233396_S_AT match to CSRP2BP but at the transcript level; half 
of their probes match to NR_028402 and rest of them match to NM_020536. The 
measured expression level is inconsistent, and does not indicate which splice variant 
changes in their expression level and is not as informative as the probe sets that matches 
to a single splice variant.  
IV. Different probe sets targeting different genes shares common probes. Such non-
specificity causes ambiguity and cross hybridization. In HG-U133 Plus 2 array total 
36,493 probes out of 603,158 (excludes quality control probes) perfectly map to 
multiple locations on the human genome assembly 38.  
V. Some of the probe sequences contain single nucleotide polymorphisms (SNPs). SNPs 
are the genetic variation between individuals of the same species [71]. A SNP 
represents a base on a specific DNA location which differs between individuals. Most 
complex diseases are associated with SNPs. For the accurate analysis of experimental 
results, SNPS located within probes need to be detected and analyzed carefully. Some 
researchers have paid attention to the effect of SNP presence in Affymetrix® probes. 
Benovoy et at. [72] concluded that SNPs located in probes cause false-positives in 
Affymetrix® Human Exon analyses and the position of a SNP within a probe sequence 
effects the binding of targets to the probes. Rouchka et al. [3, 71] designed a 
methodology to test the effect of SNPs that located in the 13th base of a probe sequence 
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to hybridization rate of mismatch probes in Affymetrix® HG-U133A arrays. They 
reported that less frequently, MM probes hybridization is greater than PM probes when 
the target probe has a SNP in the mismatch location. 
TABLE 7: The alignment of PM probes taken from HG 133 plus-2 array PM to RefSeq 
database together with their corresponding gene symbol and the designated gene taken 
from gin file. The alignments were achieved via Absolute Gene ID Conversion Tool [73]  
 Gene RefSeq Probe Set 
 228544_S_AT  228543_AT 225432_S_AT 233396_S_AT 
Designated 
Gene 
  CRP2BP 
 PET117 NM_001164811 11 11 - - 
CSRP2BP 
NR_028402 - - 11 11 
NM_020536 11 1 11 11 
 
4.2 Custom Designed CDF Files 
 Several researchers have called attention to probe-gene mapping problems [69, 74-
84]. To address these issues, they created their own CDF files in order to redesign probe 
sets. These approaches have a similar work flow but differ in the data source used, the 
selected target level (gene or transcript), whether to create probe sets from scratch or 
redesigning the existing groups and sharing probes between probe sets. Table 8 gives a 
summary of the previous work in the area of custom CDF construction. A few of them 




TABLE 8: Summary of available custom CDFs done by several researchers  
Paper Source Database Target Biomolecular 
Entities 
Number of Probes Per 
Probe Set 
Organisms Available Mapping Tool 
Chalifa-Caspi et 
al. 
GenBank, Refseq, Ensembl, 
GeneCards, UniGene 
Gene unknown Human No BLAT 
Laurent Gautier 
et al. 
RefSeq Gene/Transcripts/ALU unknown Human No 
Bioconductor Package 
matchprobes 
Dai et al. 





Human, Mouse, Rat,  
Zebrafish, ... 
Yes unknown 
Harbig et al. GenBank Transcript unknown Human No blastn 
Liu et al RefSeq, GenBank Gene/Transcript unknown 25 different Organisms No UCSC BLAT 
Lu et al. AceView Transcript 4 Human No BLAT 
Ferrari et al GeneAnnot, GeneCards Gene 6-11 Human Yes unknown 
Yu et al. 
GenBank, RefSeq, Ensembl, 
IPI 
Gene/Transcript unknown 





Leeuw et al. Entrez Gene unknown unknown Human, Mouse No unknown 
Ballester et al. Ensembl Transcript NA Human, Mouse, Rat, ... Yes Exonerate 
Risueno et al. ENSEMBL, RNAdb 
Gene/Transcript/Exon/
ncRNA 
unknown Human, Mouse, Rat Yes blastn 
Yin et al. 
Ensembl, RefSeq, GenBank, Biomart, 
ZFIN 





 Chalifa-Caspi et al. [69] worked on updating the mapping of HG-U95 arrays via a 
three step methodology without disbanding the original probe sets. First, they performed a 
pairwise alignment between probe sequences and obtained transcripts from GenBank [85], 
NCBI RefSeq [70] and Ensembl [86] via BLAT [87]. They assigned the probes to a 
transcript when probes were in the mRNA orientation and had fewer than two mismatches. 
If a probe did not match any transcript, they were then aligned to ESTs and their 
representative EST accession number was stored. In the second step, the transcript was 
mapped to GeneCard [88] genes or UniGene [66] clusters if a GeneCard gene was not 
available. In order to convert UniGene results to GeneCard, they found corresponding 
GeneCard genes of obtained LocusLink [67]/Ensembl [86] genes from UniGene [66]. If 
the result did not have an annotated LocusLink gene, their corresponding genomic 
locations obtained from UCSC [89] and used to create a link to a GeneCard entry via 
GeneLoc. Obtained ESTs were mapped to UniGene cluster.  In the last step, the transcript 
and gene annotations were recorded and used to create probe set to GeneCard annotation. 
If a probe matched to transcripts of a GeneCard gene, this probe was marked with this gene. 
In addition to marking, they calculated a sensitivity score of the probe set by dividing the 
number of major marked genes to the total number of probes and specify by finding how 
many other genes maps to this probe set and with how many probes. 
 Laurent Gautier et al.[74] also worked on Affymetrix® Human GeneChip® HG-
133A and HG-U95Av2. They aligned PM and MM probes to NCBI’s human RefSeq 
database [70] via a string matching Bioconductor package called matchprobes [90]. Only 
PM alignments were accepted. They examined the probes that matched to multiple 
reference locations in detail. They divided them into four analyzing groups. The first group 
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included the probes that matched to the same gene’s different alternative splice variants.  
They decided to keep them. The second group included the probes that matched to 300 to 
600 different locations. When they study those probes, they discovered they were designed 
to match human ALU repeats. ALU elements are highly repetitive short (around 280 to 
300 base pairs) DNA sequences [91]. Rather than removing those probes, they put all of 
them into one probe set and called it human ALU. The third group was for the probes that 
matched to closely related annotations.  Since separation of these genes requires expert 
annotators, they simply ignored them. The last group contained the probes that matched to 
multiple dissimilar annotations. They also removed them to prevent misleading analysis. 
As a result of their study, they created open source software called altcdfenvs and made it 
available to everybody as a Bioconductor package along with the data they used. However, 
it is no longer publicly available. 
 The most effective (comprehensive) study for probe-annotation remapping was 
achieved by Dai et al [75].  Rather than focusing on one reference database or combining 
multiple ones to create one custom CDF, they worked on different databases and created 
specific custom CDFs for each database. They proposed two different filtering and 
regrouping frameworks; one for the UniGene database and one for RefSeq, Database of 
Transcribed Sequences (DoTS)(http://www.cbil.upenn.edu/downloads/DoTS/), Entrez 
gene [92], Ensembl [86] gene databases. According to their manuscript [93] some of the 
UniGene cluster sequences are unreliable and the strand direction is unknown. In order to 
get accurate UniGene based probe sets, special steps were required. First they started with 
sequence alignments of probes and UniGene sequences.  
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(I) UniGene sequences were aligned to the most recent genome assembly and genome 
alignments were saved. This operation helped them to clean unreliable sequences in the 
specific UniGene cluster.   
(II) Individual probe sequences were aligned to the genome sequence. 
• Only perfectly matched probes were accepted. They also required each probe 
to have one perfect match to the corresponding genome sequence. They 
believed that the ones aligned to the non-transcript regions and one transcript 
region could be kept but it is better to remove them for more reliable results. 
(III) Individual probe sequences were aligned to UniGene and dbSNP to form new probe 
sets.  
• A probe that is a perfect match to a genomic region also must align with 
mRNA/EST sequences located in the UniGene database. The only exception 
for this rule was exon-exon junction probes that had a perfect match to mRNA 
sequence in the same UniGene cluster. They added them to the probe set with 
the lowest index number.  
• Probes that matched with multiple cDNA/EST sequences of different UniGene 
clusters were removed to make probes specific to only one UniGene cluster. 
They believed that the probes in a gene specific probe set should include the 
sequences that are common to all alternative splice variance of the gene so that 
the results were not be affected by the tissue type. Because the knowledge of 
alternative splicing genes was not complete, they decided to group all the probes 
that aligned to the same gene to create a gene specific probe set.  
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• In addition to gene specific probe sets, they created transcript and exon specific 
probe sets in order to study alternative splicing events. In addition, they created 
probe sets that target the 3ꞌ end of probes.  
• If the targeted gene does not have a known mRNA/reference sequence, they 
required that all the probes must be in the same direction on the genome. If the 
probes in a probe set were perfectly matched to genomic regions in a different 
direction and there is no mRNA/reference sequence in the UniGene cluster to 
point out the transcription orientation, they divided them into two probe sets, 
one for each direction.  
• They required all the probes, which represent one UniGene cluster, be aligned 
continuously on the genomic sequence in the same direction except when 
mRNA reference sequence of the targeted UniGene cluster aligns to the 
different locations. If the probes spread across different genome locations or 
chromosomes, the longest contiguous set of probes were used to represent the 
UniGene cluster.  
 The well defined orientation and sequence information in the RefSeq, DoTS, 
Entrez, and ENSEMBL databases let them to create new probe sets easier than the UniGene 
database probe sets.  
(I) First, they mapped the probe sequences to the corresponding genomic sequence and 




(II) After alignment, they grouped the probes that mapped to the same target and had 
correct orientation. They ordered the probes based on their location on the exon. Probe sets 
that have fewer than three probes were removed. They created gene, transcript, exon and 
3’ probe sets. 
 Besides updating probe sets based on the latest databases, they removed the perfect 
match and mismatch probes that have an allele-specific base in the center of the sequence. 
This was done to reduce the noise caused by single nucleotide polymorphisms (SNPs) in 
different samples.  These probe sets were called allele-independent.  
 For gene and transcript specific probe sets they paired database ids with GenBank 
accession numbers in order to supply more stable ids for probe sets.   
 Harbig et al.[76] worked on alternative mapping of Affymetrix® HG-133 Plus 2.0 
arrays.  Unlike the others, they mapped the target sequences of probes that were obtained 
from Affymetrix® rather than probe sequences. A target sequence is an exemplar region 
of a specific transcript. It has ≤600 bases and was used to select short oligonucleotide 
sequences (probes). Target sequences were mapped to GenBank records via blastn [94] 
with a word size of 28. They saved the human RefSeq matched results (mRNAs); if there 
were not any then they saved the matched human sequences (cDNAs).  The sequences were 
saved in the local database together with the original probe sets names and the calculated 
score based on the type of sequence and alignment. Later the probe sequences were 
compared with the collected sequences from the first step. The sequences were scored 
based on how many bases of a probe in a probe set exactly matched to the sequence.  The 
best average score across all the probes was selected and assigned as a primary 
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identification of the updated probe set. When the probe set had the same score for several 
sequences identified, the researchers marked those probe sets as detecting multiple 
transcripts. They kept the probe sets with low score values because they believed they also 
contribute. In addition, they compared probes to the most common 8 human ALU 
sequences and marked the ones matched to them. The probe sets with probes matched to a 
completely different sequence from the rest of probes was evaluated manually. If the probe 
set did not match to any sequence then it was compared to all GenBank sequences until a 
match was found. Eventually they remapped 37% of the Hg133 plus 2.0 probe sets. The 
website mentioned in the paper for methods and results are not available anymore.  
 Liu et al.[77] developed the AffyProbeMiner software to regroup probes and remap 
probes to the targets for different organisms. They used RefSeq transcripts and validated 
complete coding sequences in the GenBank as their target sequences. During the 
construction of complete coding sequence database, they obtained the sequences that 
included “complete CDS” and did not include “intronic transcript” or “BAC clone” in their 
record. And also, they obtained RefSeq mRNAs whose accession number starts with 
“NM_”. The obtained complete CDSs aligned to the genome, and the ones with less than 
99% identity were removed from the database. After that, poly(A) tails were trimmed from 
complete CDSs. As a last step of database creation, they removed one of the duplicated 
records which was mapping to the same gene or one sequence covered by the other one 
with less than or equal to 1% dissimilarity. The UCSC BLAT [87] server was used to map 
probes sequences to created database. According to mapping results, they proposed four 
different probe set grouping methods. They are transcript consistent (each probe in a probe 
set maps to the same set of transcripts), transcript unique (each probe in a probe sets maps 
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to the one transcript), gene consistent (each probe in a probe sets maps to the transcript of 
the same set of genes) and gene unique (each probe in a probe sets maps to the transcript 
of the one gene). They supplied CDFs of 25 different organisms for the R Bioconductor 
environment, Affymetrix® GCOS and dChip. They claimed that providing a flexible tool 
to create a CDF file and using the BLAT server and Perl (They provided faster process 
than only using R) made their work better than others. Currently their tool, CDF files and 
web site are not publicly available. Their method remapped the 65.6% of probe sets on 
HG-U133A array. 
 Lu et al. [78] proposed a method that differs from others by the target database 
used. They used the human transcript database AceView [95]. The AceView database was 
formed from GenBank, dbEST and RefSeq mRNAs. Since it is a combined database, more 
transcripts are covered than other databases thereupon mapping between probes and 
mRNAs resulted with more matching. They matched a probe with a transcript when the 
number of identical bases between them is more than 21 (out of 25 length probe sequence). 
The probes with the same target(s) grouped together and composed one probe set. They 
made sure that probe sets never share probes. To uncover the effects of the number of 
probes per probe set over expression results, they created artificial data sets from the 
Affymetrix® U133A Latin Square data [96] and ran simulations over them. Latin square 
data is a test dataset provided by Affymetrix® to develop and compare analysis methods. 
It is formatted as Latin square; nxn array of n different symbols in which each symbol 
occurs only one in each row and in each column of the array. They analyzed the data with 
the specially designed CDF which contains probe sets of randomly selected probes with a 
variable number. i.e. for CDF d2, two random probes selected from each probe set. 
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Simulation results clarified that when the number of probes in a probe set increase, the 
reliability of expression measurements enhanced and the number of false positives 
decreased. There is a prominent difference between the probe set size smaller than four and 
bigger than three. Therefore, they only kept the probe sets with more than three probes. 
The web site provided in the paper is not available anymore. With their proposed method 
only 22% of original probes stayed without any change.  
 Ferrari et al. [79] worked on developing CDFs for Affymetrix® human arrays based 
on the GeneAnnot [69] database. GeneAnnot contains the relationship between the 
Affymetrix® probes and transcript sequences obtained from cDNAs, GenBank, RefSeq 
and Ensembl. The probes were matched to obtained transcripts from previously mentioned 
databases and then linked to GeneCards. Chalifa-Caspi et al. gave a more detailed 
explanation of GeneAnnot construction methods already explained in this chapter. In 
GeneAnnot, a gene was described with the HUGO gene nomenclature committee (HGNC) 
database, Entrez Gene and Ensembl. All individual probes linked GeneCards gene reached 
from GeneAnnot and the ones that linked to the same gene combined to create new probe 
set. They created two CDF files; one had at least six probes per probe set and other one had 
at least 11 probes per probe set. They analyze the same data with brain array CDFs, 
AceView CDFs and their CDFs to compare the obtained differentially expressed genes. 
They used robust multi-array average (RMA)  [97] and significance analysis of microarrays 
(SAM) [98] methods in R environment for analyzing. Most of the time around 40% of the 
genes was commonly detected by all the CDFs. The highest similarity (on average 82%) 
was obtained when their CDF’s results were compared with brain array [75] Entrez and 
RefSeq CDF results. Affymetrix® arrays can be obtained from 
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http://genecards.weizmann.ac.il/geneannot/customcdf.shtml. They also supply a search 
engine to get specific information of a probe set and gene. 
 Yu et al. [80] were only interested in the probe sets that target the protein coding 
transcript. For this reason in addition to GenBank, RefSeq and Ensembl, they used the IPI 
(International Protein Index) [99] database to connect mapped mRNAs to external protein 
accession numbers and get only the probes that target protein coding sequences. At first 
they got the original probe set gene mapping information from the Affymetrix® NetAffxTM 
[65] website. As mentioned in the paper their blast procedure based on the GeneAnnot 
approach developed by Chalifa-Caspi et al. (summarized previously). Later they connected 
the selected target mRNAs from blast filter to the protein IDs in IPI database.  Connected 
protein IDs were used to create new probe sets. As a result some of the probes classified to 
four groups; transcript unique (all the probes mapped to one protein), gene unique (all the 
probes mapped to alternative spliced proteins of same gene) cross-hybridize (maps to 
proteins of multiple genes) and not categorized (not connected to any protein). The probes 
that did not map to any protein were eliminated. When the probe matched to multiple 
variants of the same gene they annotated it with gene level annotation. When probe 
matched to the single variant of a gene they annotated the probe in transcript level. At the 
end they covered the 85.4% of original Affymetrix® target genes and 68.8% probes were 
kept in the new CDF file. 
 Leeuw et al. [81] believed that probes removed during custom CDF creation might 
be important for researchers to study not yet well established genes and proposed a method 
called CDF-Merger. CDF-Merger aims to regain the lost information due to removed 
probes by creating Hybrid CDFs from Affymetrix® CDF, Affymetrix® annotation files, 
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Brainarray custom CDFs and NCBI Entrez Gene Info Files. First they customized the 
Affymetrix® CDF and Brainarray CDF. The rules of customizing Brainarray CDF are: (I) 
Redefine the probe-set ids (atd_Entrez) to be able to track (II) Put “_d” to the probe set 
name when probe set has probes that is shared with other probe sets. The rules of 
customizing Affymetrix® CDF are: (I) Keep the original Affymetrix® probe set names for 
tracking. (II) Discard the probe sets that contained more than two probes which was already 
used in Brainarray CDF. (III) If a probe set shares one or two probes with Brainarray probes 
then remove the probes from probe set and keep the rest the probes, add _1 or _2 to the 
probe set name. (IV) Check the Affymetrix® annotation file with NCBI Entrez GeneInfo. 
If a probe set can be annotated by more than one Entrez id then leave annotations of these 
probe sets empty. (V) Remove the annotations of probe sets already targeted in the 
Brainarray CDF. (VI) Rename all the probe set names with pattern “atm_Entrez_id”. (VII) 
Unite the probe sets that share the same Entrez id and mark them by putting _m to their 
name. After customization they combined the all probe sets into one CDF and created R 
environment CDF. 
 Ballester et al. [82] performed annotations for multiple organisms. They started 
updating by mapping PM probes to the corresponding genome via the exonerate alignment 
tool [100]. They discarded the probes that aligned to genome with more than one mismatch 
and probes that aligned to more than a hundred times on the genome. Later on they mapped 
probe sets to the Ensembl transcripts. If at least half of the probes in a probe set mapped to 
a specific transcript then they annotated the probe set with this transcript. The results can 
be reached from the Ensembl web site. From the BioMart search tool [101], one can get all 
the annotations for a specific array. In addition to web access, BioMart can be also accessed 
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via the R programming language with the Bioconductor package biomaRt. They also have 
a perl API to let users reach the data. The annotated GeneArrays are arrays are from 
Affymetrix®, Illumina and CodeLink. 
 Risueno et al. [83] worked on updating probe mappings of Affymetrix® human, 
mouse and rat microarrays and shared the results, files and created tools from a web site 
called GATExplorer (Genomic and Transcriptomic Explorer). As in other studies they 
mapped the probe sequences to the target database and annotated them according to the 
mapping results. Mapping was performed with blastn. Target sequences of mRNAs and 
cDNAs were obtained from Ensembl. Only PMs were accepted. Different than other 
approaches, they mapped probes that were not mapped to the coding regions to the non-
coding RNA (ncRNA) and created CDFs from the mapping results. They used Ensembl 
and RNAdb [102] as a source for ncRNAs. The CDFs are classified into four groups: 
probes to gene loci, to transcripts, to exon and to ncRNA. They can be downloaded as an 
R library. They supply txt files that show the mapping of probes to gene loci and transcripts 
with Ensembl id, gene name and symbol. One can search a specific gene and examine it 
with the visualization of loci, transcripts, exons and mapped probes on a chromosome. 
They also give a presentation of gene expression patterns obtained from GeneAtlas [62] 
based on probe sets for a specific gene. In addition to gene based search, probe set, genome 
coordinate, sequence of nucleotide and amino acids based searches can be performed from 
the web site. 
 Yin et al [84] adopt the Dai et al.’s proposed method with some main changes to 
remap Affymetrix® zebrafish genome arrays. To determine genome specific probes, first 
they mapped the probe sequences to genome version 7 via Exonerate. They removed the 
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probes that did not match the genome and transcripts or matched to multiple locations. To 
be able to detect cross exon boundaries, they kept the probes that had no matching to 
genome but matched the transcript. Later the probes were aligned to transcripts that were 
composed from Ensembl, RefSeq, GenBank, Biomart, and ZFIN [103]. They downloaded 
the transcriptome alignment coordinates and coding sequence coordinates from the UCSC 
genome browser and followed the procedure Exlink [104], proposed by the Ensembl group, 
to organize transcripts of different databases. The idea behind Exlink is clustering the 
transcripts under same gene when their coding regions are overlapped. During the mapping 
process, the probes that mapped to multiple genes, intergenic regions or introns of genes 
were removed. The probes that passed the filtering step were clustered based on the 
transcripts they mapped. One specific cluster was either representative of a transcript or 
multiple common transcripts of the same gene. Since the reverse complementary probes 
generates weaker signal than positive strand probes, they were grouped separately from 
positive strand probes. They also wanted to pay attention to the effect of the selected 
database over probe remapping by performing an experiment. They examined the one 
specific data set with probe mapping created based on Ensembl and probe mapping created 
based on a multiple source database, UCSC. The differently expressed genes detected by 
multiple databases were more comprehensive than Ensembl and the multiple source 
database was also able to detect more alternative splicing events than Ensembl. To 
strengthen their conclusion they performed real time PCR validation for a select number 
of genes. Only UCSC were able to detect PCR validated genes.  
 In our work we also redefine the mapping between probe sets and target genes by 
creating custom CDFs (Chip Description File) based on the latest genomic information. In 
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contrast to previous approaches we annotated probes in UTR and individual exon levels in 
addition to gene and transcript levels. Furthermore, we used interval alignment via Nested 
Containment List (NCList) rather than sequence alignment. We also provide flexibility for 





COORDINATE MAPPING BETWEEN PROBES AND ANNOTATIONS 
 Mapping between sequences, genomes and genome annotations is one of the main 
process of bioinformatics related works. For example, assembly of multiple sequences is 
used to construct the complete genome of an organism. Mapping between a query sequence 
and specific regions of an organism genome is used to identify annotations of the query 
sequence. Mapping used for comparative genomics query deals with finding common 
annotations between different genomes. 
In bioinformatics, biological annotations in a genome such as genes, transcripts, 
UTRs, exons, introns and SNPs are modeled as intervals. For example, the human gene 
GRIK4 is located on the chromosome 11 of human genome assembly 38, starts at 
120,511,700 and ends at 120,988,904. It has twenty-one exons. One of exons whose 
Ensembl id is ENSE00003810695, starts at 120,511,887 and ends at 120,511,887. 
Therefore, finding annotation of a query sequence requires coordinate mapping. In our 
research, we used coordinate mapping to update mapping between probes and target genes 
by searching coordinates of a probe against coordinates of a genome.  
Several structures have been applied to interval overlap searches in genomics. A 
BTree (MySQL database) with binning method has been used by the UCSC genome 
Browser [89]. The binning method partitions data into hierarchical bins and search the  
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intervals only in the matching bins. But it is not efficient for counting overlaps because all 
candidate bins need to be searched to find possible overlaps. R-tree indexing can also be 
applied for interval overlap searching. One of the variation of the general R-tree is interval 
trees. Interval trees are used by composing the tree from genomic coordinates of genes and 
searching coordinates of probes in the tree. Another faster and widely used way of 
performing interval overlap search is creating interval database representation of genomic 
coordinates via nested containment list (NCList) and searching probe coordinates in the 
NCList database. In our research, since the probes within a probe sets are short nucleic acid 
sequences, their genomic coordinates are not defined. We used the Bowtie alignment tool 
to obtain the genomic coordinates of probe sequences. It was also used to detect nonspecific 
probes. After obtaining probe coordinates, we used Nested Containment List (NCList) to 
perform mapping between probes and genomic annotations.  
5.1 Bowtie 
 Bowtie (http://bowtie-bio.sourceforge.net/index.shtml) is a tool for aligning short 
read sequences to the large genomes [53]. It is fast and memory efficient. There are two 
main versions: bowtie 1 and bowtie 2. Bowtie 1 allows alignment of short reads to long 
reference genomes (e.g. mammalian). Bowtie 2 allows alignment of relatively long reads 
(100s of characters) to long reference genomes. It provides gapped, local and paired-end 
alignment modes. 
 Bowtie’s reference genome is indexed with a Burrows-Wheeler transform so that 
its memory footprint becomes small. It uses an extended version of exact mapping called 
inexact matching to align short reads to an indexed genome. Backtracking and double 
indexing are two major extensions. It allows mismatches with high quality alignments 
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through the quality aware backtracking. Bowtie avoids excessive backtracking via double 
indexing. 
 In our work we used bowtie version 1.0.1 to align short probe sequences to the 
genome thereby the probes that no longer align to a genomic location or perfectly align to 
multiple genomic locations are removed and cross-hybridization effects are reduced. The 
following sections describe the algorithms used by Bowtie. 
5.1.1 Burrows-Wheeler Transform 
 Burrows-Wheeler transform (BWT) is an algorithm developed for efficient data 
compression (Fig 36). It takes a character string and rearranges it. The result of the 
transformation contains the exact same characters that were started with, differing only in 
their ordering. It is useful for compression because it orders repeated characters next to 
each other and makes the data more compressible by algorithms such as run-length 
encoding [105]. Because it allows large texts to be searched efficiently with a small 
memory requirement, it is applied to sequence alignment in bioinformatics. The 
transformation is reversible.  
 
Figure 36: A Burrows-Wheeler transform (BWT) 
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Without any additional data, BWT of a character string supplies information for:  
• The number of occurrences of a specific character in the text. 
Since the BWT(T) is the permutation of the original text, we can count the number of 
occurrences of a character in the BWT(T). 
• Reconstructing the first column of the matrix M.  
BWT(T) has all the characters in the text. Sorting the BWT(T) lexicographically will 
return the first column of the matrix M. 
• Whether a specific two characters length substring is present or not in the original text. 
The first property of Last-First (LF) Mapping formulated by Ferragina and Manzini 
[106] is used to search for a substring. BWT(T) is ordered lexicographically and the 
rows that has the first character of the substring are used as index to look for the second 
character of the substring in the BWT(T). If at least one of the marked rows has the 
second character then we can say that the original text has the substring. 
• The second column of the matrix M. 
It can be recovered by Last-First (LF) Mapping. From the last and the first columns, 
we can get the set of two consecutive characters in the original text. Since each row of 
the matrix M is cyclic shift, the same consecutive characters must be occurred between 
the first and the second column also. Based on this property, we can fill the second 
column. The same property is also used to recover the rest of the matrix M. 
5.1.2 Inexact Matching  
 To map reads to the genome one must consider sequencing errors, mismatches, and 
genuine differences between the reference and query. But the exact matching does not 
handle these conditions. To make exact matching appropriate for genome mapping, bowtie 
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developed an algorithm called inexact matching. It uses backtracking to find alignments 
that satisfy the alignment policy which “allows a limited number of mismatches and prefers 
alignments where the sum of the quality values at all mismatched positions is low” [53].  
 The procedure of inexact matching is similar to the exact matching unless range 
does not become empty. When the range becomes empty, the algorithm might replace 
already matched query position by another base to allow mismatches between the reference 
and the query and then search resumes after the mismatch position. To substitute a base, it 
has to be consistent with the alignment policy and modified query has to be present in the 
text. When there are multiple candidates for substitution position, the position with a 
maximal quality is selected.  
 Backtracking was implemented via a stack data structure. The stack structure grows 
when a substation candidate selected and shrinks when the substation candidate is rejected. 
The alignment found via Bowtie might not be the best possible alignment in terms of 
number of mismatches and quality but the tool allows user to select best option to find the 
best possible alignment in terms of the number of mismatches. But it comes with a time 
cost. 
5.1.3 Double Indexing 
 When more than one mismatch is allowed, a search might be too slow because of 
excessive backtracking. To avoid this, bowtie introduced a new technique called double 
indexing. Bowtie indexes both the genome (forward index) and reverse (character reverse) 
of the genome (mirror index). Searching the mirror index with reversed query is the same 




Figure 37: Exact matching versus inexact alignment. (figure adapted from [53] under 
Creative Commons Attribution Non-Commercial License) 
5.2 Interval 
An interval is a value pair of real numbers [a,b] such that a ≤ b. It represents the set 
{x є R : a ≤ x ≤ b}. a and b called the endpoints of the interval. The endpoints can be 
included or excluded from the set. 
• When both endpoints are excluded from the set, it is called an open interval. They 
are represented as: 
(a,b) = ]a,b[ = {x є R | a < x < b} 
• When one endpoint is included in the set, it is called a half-open interval. They are 
represented as:  
[a,b) = [a,b[ = {x є R | a ≤ x < b}  OR (a,b] = ]a,b] = {x є R | a < x ≤ b}   
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• When both endpoints are included in the set, it is called a closed interval. They are 
represented as: 
[a,b] = [a,b] = {x є R | a ≤ x ≤ b}  
Between two intervals x and y, there can be three different relations. 
• x and y overlap when low(x) ≤ high(y) and low(y) ≤ high(x).  
• x is to the left of y when high(x) ≤ low(y). 
• x is to the right of y when high(y) ≤ low(x). 
5.3 Interval Tree 
 An interval tree is an augmented red-black tree [107]. It provides efficient access 
to set of intervals (Fig. 38). 
A red black tree is a binary search tree with extra color information. The color makes 
the tree approximately balanced by controlling the node coloring for every path from a 
given node to any of its leaf. A red-black tree must satisfy the following properties: 
1. “Every node is either red or black. 
2. The root is black. 
3. Every leaf (NIL) is black. 
4. If a node is red, then both its children are black. 
5. For each node, all paths from the node to descendant leaves contain the same 
number of black nodes.” [107] 
 Every node in an interval tree contains extra two fields; an interval defined by low 
and high value pair and the maximum value stored in the subtree of the node. 
max[x] = max(high[x], max[left[x]l, max [right [x]]) 
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 In our examples the intervals are closed. An interval tree is ordered by low values 
of each interval. Thus, the in-order traverse returns the intervals ordered by low borders. It 
allows insertion, deletion, and search operations. Since an interval tree is a red black tree 
and height of the red black tree is smaller or equal to 2lg(n+1) (n is the number of nodes 






Figure 38: An interval tree example. (a) A set of intervals (b) The interval tree 






5.3.1 Interval Tree Operations 
• Search 
 A search operation takes an interval such as [low(x), high(x)] and looks for 
overlapping intervals in the tree.  
 Fig. 39 shows the pseudo code of interval tree search taken from Cormen et al. 
[107]. The function takes interval tree T and interval i. It either returns the interval that 
overlaps to i or the sentinel nil[T].  The search starts from the root, continues downward 
through the three and terminates when overlapped interval found or x points to the sentinel 
nil[T].  
INTERVAL-SEARCH(T, i) 
1 x  root(T) 
2 while x ≠ nil(T) and i does not overlap int[x] 
3     do if left[x] ≠ nil[T] and max[left[x]] ≥ low[i] 
4           then x  left[x] 
5           else  x  right[x] 
6 return x 
Figure 39: Interval tree search pseudo code 
• Insert 
 The insert operation takes the root of the interval tree and the interval as an input. 
It searches for proper position based on the intervals low end and inserts the interval via 
updating left, right and root pointers of the affected nodes. After insertion, the interval tree 






The delete operation is similar to insert. It takes the root of the interval tree and an 
interval as an input. It searches for proper position based on the intervals low end. Along 
the way the max field of nodes and balance factors are updated. 
5.4 Nested Containment Lists 
Nested Containment List (NCList), interval database representation, was developed by 
Alexander V. Alekseyenko et al. [108] to overcome the difficulties of finding overlapping 
sequence intervals in exponentially growing sequence databases.  
Typically time complexity of finding the first overlapping interval to a query is O(log 
N) in a database composed of N intervals. But in most cases, interval search requires 
finding all overlapping intervals. Since intervals are not guaranteed to be contiguous on 
both start and end coordinates, a search cannot end when the first overlapping interval is 
found. For example, Fig. 40 demonstrates querying in two databases. In Fig. 42a intervals 
are ascending ordered based on interval start coordinates. In this type of structure, 
overlapping intervals might be spread all over the structure. Thus, on average half of the 
structure needs to be searched to find all overlapping intervals. 
If one looks carefully at the start coordinate ascending ordered interval list, it can be 
seen that intervals contained within another interval prevent them from being sorted based 
on both start and end coordinates. This problem can be solved by removing contained 
intervals because if an ascending ordered list of intervals does not have contained intervals, 
it will be also sorted based on end coordinates. Thus, when the first non-overlapping 




Figure 40: Difference between start coordinate sorted database and a NCList data 
structure. Intervals shown in bold are overlapping intervals with the query interval (figure 
adapted from [108] under Creative Commons Attribution Non-Commercial License) 
Alexander V. Alekseyenko et al. created NCList to partition the intervals into 
subsists so that in each partition no interval is contained by another interval. For example, 
in Fig. 42b the first sub-list contains an ascending ordered list of 7 intervals. Additional 
sub-list intervals that fully overlap with an interval in the predecessor sub-list are shown in 
a separate box. As seen from the Fig 41b, detected overlapping intervals (shown in black) 
are located back to back in each of the sub-list. Since the NCList structure guarantees that 
a sub-list contains only non-overlapping intervals, after a non-overlapping interval to a 
query interval is found, the search can be halted. In this way the time complexity of finding 
all overlapping intervals to a query interval is reduced to O (log N + n). N represents the 
number of intervals contained in the database of intervals and n represents the number of 
overlapping intervals to the query interval. 
5.4.1 NCList Data Structure 
An NCList structure is composed of two arrays; the sub-list headers array (H) and 
the interval array (L) (Fig 41). The sub-lists headers array (H) stores the record index of 
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first element and its length for each sub-list Sx. The interval array L stores the sub-lists 
indexed in H.  
 
Figure 41: “Schematic representation of NCList data structure. Here in the 
interval array L, element L[i] has non-empty sublist, which records is indexed in sublist 
header array H by L[i]. SUBLIST. This sublist starts at START and has length LENGTH. 
L[i] itself belongs to the top level list S0, which has sublist header H[0]” (figure adapted 
from [108] under Creative Commons Attribution Non-Commercial License) 
5.4.2 Query of overlapping intervals  
Query of overlapping intervals composed of recursive 3 main steps: 
1) Binary search in a sub-list Sx. 
2) Scan in the sub-list to return overlapping intervals that has a sub-list. 





Figure 42: NCList overlap query pseudo code [108] 
 The time complexity of this algorithm is O(log(N/α) + n). N is the size of the 
intervals database, α is the average number of intervals contained in any top-level interval 









 We developed an Affymetrix® GeneChip® probe remapping protocol at the level 
of genes, transcripts, untranslated regions (UTRs) and individual exons based on the 
genome and Ensembl annotations. The protocol takes annotations in a General/Gene 
Transfer Format (GTF) file (see Section 3.3.3), generates a Custom Chip Description File 
(CDF) where probes are grouped into probe sets based on region (UTR, individual exon), 
transcript or gene level. Here, we define individual exons as coding exons within protein 
coding genes, or all exons within structural RNAs (such as miRNA and lncRNA). In effect, 
the individual exons refer to all non-UTR portions of exons. The region based grouping is 
beneficial to profile the contribution of UTR, and exon regions to the gene expression 
levels globally as well as their independent differential expression which may play a 
significant biological role. The gene and transcript based CDFs allow obtaining gene 
expression levels of interest based on the latest genomic information. Since annotations 
rely on the input file provided by the user, it gives researchers the opportunity for analysis 
based on a specific set of annotations. 
6.1 Steps for Generating Custom CDFs 
Custom CDF generation is composed of three main steps: mapping probes to the 
genome, annotation of probes, and assignment of probes to probe sets based on annotations.
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 Fig. 43 shows the flow chart of annotation and grouping of probes based on the 
region of a gene. After the probe sequences are mapped to the latest assembled genomic 
DNA sequences via Bowtie [53] version 1.0.1, the probes were annotated based on the 
overlapping between probes and gene structures taken from the GTF file using NCList. 
Probes that share the same annotation were grouped into one probe set. Annotations vary 
according to the type of CDF file. For region level custom CDFs, probes were mapped to 
the 5ꞌ and 3ꞌ UTR, and individual exon start and end locations of every gene and probe sets 
were named according to the gene id and region. For the gene level custom CDFs, probes 
were mapped to the start and end locations of every gene and probe sets were named 
according to gene id. For transcript level custom CDFs, probes were mapped to the start 
and end locations of every transcript and probe sets named according to transcript id. In 
every step different filtering criteria are applied for each CDF file. 
6.1.1 Mapping of Perfect Match Probes to a Genome 
 PM probe sequences, which can be obtained from the Affymetrix® 
Netaffx™ analysis center web site or GEO in a FASTA file format, are aligned to the 
indexed genome using Bowtie version 1.0.1 with the parameters -v 0 and –m 1, requiring 
that probes align to a single genomic location with 100% identity, thereby the probes that 
no longer align to a genomic location or perfectly align to multiple genomic locations are 
removed and cross-hybridization effects are reduced. Note that Bowtie version 1 is best at 
aligning shorter sequences (25-50 bp) as found with microarray probes while the most 
recent versions of Bowtie are optimized for long sequence reads (>50 bp). Mismatch (MM) 
probes are not considered in the mapping step, although they could theoretically map 
uniquely to genomic regions. Rather, the MM probes are set aside and are included with 
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their corresponding PM probe during the final CDF construction step once the PM probes 
have been assigned to a probe set. During this analysis, only probes perfectly matching to 
a region are considered.  Therefore, probes crossing splice junctions will be discarded. The 
following is a line taken from the alignment results of Affymetrix® HG-133 Plus 2 to the 
HG38 genome index. 
probe:HG-U133_Plus_2:1053_at:987:1005; Interrogation_Position=1216; Antisense;      -    7  74232149 
 
 
Figure 43: Flow chart for region-based probe annotation framework 
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 Until the end of the last semicolon, the line includes the information taken from the 
Affymetrix® HG-133 Plus 2 probes FASTA file. The rest of the line shows that the probe 
was aligned to the antisense strand (- for antisense, + for sense strand) on chromosome 
seven starting at base 74,232,149. 
6.1.2 Annotation of Perfect Match Probes via NCList 
 Probes were annotated based on the overlap between probes and genomic intervals 
by the following steps.  
I. General/Gene Transfer Format (GTF) files for the studied species were obtained from 
the Ensembl [86] ftp server. Each GTF is a tab-delimited text file used to represent 
gene structure information, including the start and end positions of a gene together with 
chromosome location. Each structure is tagged with a feature which can be gene, 
transcript, exon, start_codon, stop_codon, CDS or UTR. Fig. 44 shows structure tags 
marked with red lines for the FO538757.2 gene located in the 
Homo_sapiens.GRCh38.85.gtf. It has one transcript that composed of three exons. It 
also has CDS, start_codon, stop_codon and five_prime_utr together with the start and 
end positions. Ensembl GTFs were used since the annotations are determined by an 
automated system based on experimentally verified data combined from multiple 





Figure 44: Features of the FO538757.2 gene in GTF 
II. A nested containment list (NCList) index was created for each chromosome from 
intervals (start and end points) of gene structures. The intervals of the NCList were 
selected based on the target of the probe sets. When the probe sets were constructed 
based on gene or regions of a gene, we used UTR and individual exon intervals. For 
transcript targeted probe sets, we used transcript intervals.  
III. Probe intervals were searched in the NCList indexing and annotated according to the 
overlapping results. Probes were split based on the matched chromosome. Each probe 
group interval was searched in the same chromosome’s NCList indexing. When an 
overlap was found, the probe was annotated with the list node. Only complete overlaps 
were accepted; both the low and high ends of the interval must be included in the list 
node. The probes which did not overlap the nodes were discarded. As a result, probes 
partially overlapping UTRs, and individual exons will not be included at the region and 
gene level, but will be present at the transcript level. Table 9 shows the annotations for 
the Affymetrix® HG-133 Plus 2 probes which were located on chromosome six and 





TABLE 9: Probe annotation outputs at the end of NCList indexing search 
Probe Start End Annotation 
223120_at:528:909 143501994 143502018 ENSG00000001036_exon 
223120_at:861:491 143501942 143501966 ENSG00000001036_exon 
223120_at:683:349 143497416 143497440 ENSG00000001036_exon 
223120_at:949:165 143495814 143495838 ENSG00000001036_exon 
223120_at:585:237 143495755 143495779 ENSG00000001036_exon 
223120_at:605:739 143495514 143495538 ENSG00000001036_exon 
223120_at:605:739 143495514 143495538 ENSG00000001036_UTR 
223120_at:543:383 143495501 143495525 ENSG00000001036_exon 
223120_at:543:383 143495501 143495525 ENSG00000001036_UTR 
The following are pseudocode snippets for generating CDFs. 
Region Based CDF 
Get probe intervals and chromosome locations from the text file 
Get intervals of individual exons and UTR for each gene from gtf file 
Split intervals based on chromosome location 
For each chromosome chr { 
Split intervals based on gene region (exon, UTR) 
For each gene { 
For each region 
Combine overlapping intervals 
} 
Create NCList indexing of intervals belong to the chr 
For each probe located on chr  
Search probe interval in the NCList indexing 
Annotate probe with region intersecting gene 
} 
Create probe sets 





Transcript Based CDF 
Get probe intervals and chromosome locations from the text file 
Get intervals of transcripts for each gene from gtf file 
Split intervals based on chromosome location 
For each chromosome chr { 
Create NCList indexing of intervals belong to the chr 
For each probe in chr  
Search probe interval in the NCList indexing 
Annotate probe with intersected transcript 
} 
Create probe sets 
Write probe sets into ASCII CDF files 
 
Gene Based CDF 
Get probe intervals and chromosome locations from the text file 
Get intervals of individual exons and UTR for each gene from gtf file 
Split intervals based on chromosome location 
For each chromosome chr { 
Split intervals based on gene region (exon, UTR) 
For each gene { 
For each region 
Combine overlapping intervals 
} 
Create NCList indexing of intervals belong to the chr 
For each probe located on chr  
Search probe interval in the NCList indexing 
Annotate probe with intersected gene of the region 
} 
Create probe sets 




IV. A probe’s start and end points may overlap multiple genomic structures. It may overlap 
with the UTR and individual exon region of the same gene (as seen in table 9) or with 
multiple genes or transcripts. To remove cross hybridization and ensure probes 
uniquely map to a single region, gene or transcript, we choose one of the annotations 
for each probe and remove the remaining matches. The rule for assigning these probes 
occurs with the following priority (I) 5′ and 3′ UTRs; (II) individual exons. Thus, 
although UTR regions technically occur within exons, the more specific UTR 
assignment will be used. When the annotation was based on gene or transcript the first 
obtained annotation was selected.  
In the previous example, probe 223120_at:543:383 overlaps both the exon and UTR 
region of the FUCA2 (ENSG00000001036) gene (Table 9). During filtering, matching 
between the probe and the exon will be removed because our first preference is UTRs 
(preference order 5ꞌ UTR - 3ꞌ UTR – individual exon). Because of preference in the 
CDF the probe will be only used to represent the UTR region of the FUCA2 gene. 
V. Probes with the same annotation were grouped together to form a probe set. 
For example, in the previous example, 223120_at:528:909, 223120_at:861:491, 
223120_at:683:349, 223120_at:949:165, 223120_at:585:237 will form a probe set to 
represent the individual exon region of the FUCA2 gene. Fig. 45 shows the grouping 
of probes for three types of CDFs. These CDFs are: 
o Region-based CDF: Probe sets are designed to target a specific region of a gene 
and consist of probes which map to the same region (UTR, individual exon) of 
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a gene. In Fig. 45, green probes were mapped to the UTR region of Gene_1; 
therefore, those probes cluster together to form the Gene_1 UTR region probe 
set. Based on the same logic, blue colored probes form the probe set for Gene_1 
exon. 
o Gene-based CDF: Probe sets are designed to target genes and consist of probes 
which map to the same gene. In Fig. 45, green and blue colored probes, which 
mapped to Gene_1, cluster together to form the Gene_1 probe set. 
o Transcript-based CDF: Probes that map to same transcript of a gene compose a 
probe set. In Fig. 45, the orange and red arrow show the start and end positions 
of Transcript_1 and Transcript_2. The probes mapped to the Transcript_1 (two 
greens, five blues) cluster together to form the probe set for Transcript_1. 
 
Figure 45: Creating probe sets for different types of custom CDF based on probe 
mapping to genomic structures 
VI. Probe sets were saved into ASCII format CDF files. In addition to the probes specific 
for a particular gene, Affymetrix® GeneChips® contain a number of different control 
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probes such as probes that are added during sample preparation, providing evidence 
that assay was performed properly. We added those probe sets to our CDFs without 
any change.  
6.1.3 Probe Set Naming 
 Since GTF files obtained from Ensembl were used, Ensembl gene ids were 
employed to distinguish different genes and Ensembl transcript ids were used to distinguish 
different transcripts. When the generated CDF was based on regions of genes, the region 
was suffixed to the Ensembl gene id. Strand direction specified in the GTF of the genomic 
structure is also suffixed (- or +).  Table 10 shows example probe set names taken from 
custom CDFs for the Affymetrix® GeneChip® HG-133 Plus 2. 
TABLE 10: Custom CDF naming examples 










affyCustomCdf: AN R PACKAGE FOR CREATING CUSTOM CDF 
We developed an R package, affyCustomCdf, for allowing users to create custom 
CDFs via removing nonspecific probes, updating probe target mapping based on the 
supplied genome information and grouping probes into region (individual exon, UTR), 
gene and transcript levels. It has been implemented in R and C++ languages based on the 
Bioconductor package requirements and publicly available at 
https://github.com/UofLBioinformatics/affyCustomCDF. 
7.1 affyCustomCdf Tool 
  To create a custom CDF via affyCustomCdf tool, one must call the 
createAffyCustomCdf function after installation of the tool. The createAffyCustomCdf 
function produces a custom CDF based on parameters this includes the original CDF, probe 
alignment file and annotation (GTF) file which must be supplied by the user. The remaining 
parameters are optional, with a default value set (for more details see appendix). Fig. 46 
describes the parameter selection for creating a custom CDF via the affyCustomCdf tool. 
7.1.1 Custom CDF Types 
 The affyCustomCdf tool can produce main three types of custom CDF. They are 
region-based, gene-based and transcript based.
 99 
 
• Region based CDF: In region based custom CDFs, probe sets consist of probes 
which map to the same region (individual exon, UTR) of a gene. It can be obtained 
via supplying “regionG” value to the type parameter of the createAffyCustomCdf 
function. 
• Gene based CDF: In gene based custom CDFs, probe sets consist of probes which 
map to the same gene. It can be obtained via supplying “gene” value to the type 
parameter of the createAffyCustomCdf function.  
• Transcript based CDF: In transcript based custom CDFs, probe sets consist of 
probes which map to the same transcript of a gene. It can be obtained via supplying 
“transcript” value to the type parameter of the createAffyCustomCdf function.  
In addition to main three types supplied above, files can be diversified via defining 
rules for probe selection and directional relationship between probes and annotations.  
Three different types of custom CDF can be produced based on the sense/antisense 
relationship between probes and annotations. They are no direction, same direction and 
opposite direction. 
• No direction CDF: When no direction rule is applied, direction will not be 
considered during probes to annotations mapping. This can be performed via 
supplying “0” value to the SD parameter of the createAffyCustomCdf function.  
• Same direction CDF: When same direction rule is applied, mapping is performed 
between same directions such as sense probes can only map to sense annotations. 




• Opposite direction CDF: When opposite direction rule is applied, mapping is 
performed between opposite directions such as sense probes can only map to 
antisense annotations. This can be performed via supplying a value except 0 or 1 to 
the SD parameter of the createAffyCustomCdf function. 
Probe selection can be defined in two ways. Allowing probe share between transcripts 
of a gene or removing a probe according to the number of matched annotations to the 
probe.  
• Use probes map to one annotation: When unique probe option is selected, probes 
that maps to more than one annotation are discarded from a region-based CDF. This 
option is provided to allow users to examine unique probes to one specific 
annotation. It can only be used with the regionG type. Selection can be supplied to 
the createAffyCustomCdf function via uniqueProbe parameter. Possible values are 
FALSE for not unique probes, TRUE for unique probes. 
• Share probe between transcripts of a gene: In the case of transcript based custom 
CDFs, when an exon is shared between transcripts of a gene, only one of them can 
have probes that maps to the exon because we choose one of the annotations that a 
probe maps and remove the remaining matches (See chapter 6 for more details). 
Via share probe between transcript of a gene option, probe sharing between 
transcripts of a gene is allowed. This option is provided to cover more transcripts 
in the CDF and supply more accurate predictions for every transcript of a gene via 
having more probes per probe set. 
The last option that creates diverse CDF is junction tolerance.  
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• Junction tolerance file: Junction tolerance allows CDFs to include probes that 
map to the junctions of annotations via merging overlapping and consecutive 
intervals of same structures before creating NCList indexes. For example, in 
Rat assembly rn6 the PRR4 gene has four transcripts. One of the transcripts 
(ENSRNOT00000078821) has an exon (ENSRNOE00000523383) that starts at 
167,483,620 and ends at 167,483,880. Another transcript 
(ENSRNOT00000038396) has an exon (ENSRNOE00000557210) that starts at 
167,483,881 and ends at 167,483,910. When junction is not allowed, a probe in 
Rat 230 2.0 microarray with 167,483,620 and 167,483,887 coordinates will not 
be annotated with PRR4-exon because it does not align to an individual exon. 
When junction is allowed a new interval 167,483,620 and 167,483,910 will 
represent the PRR4-exons and the probe will be annotated and placed in the 
produced custom CDF.  
7.1.2 Interpreting Results  
 The affyCustomCdf tool produces three files. They are custom CDF file, report file 
and missing probes file. 
• Custom CDF file: Produced custom CDF file consists of regrouped probes into 
probe sets based on specific annotations of interest. It is used for data analyses 
of Affymetrix® GeneChip® data. 
• Report File: Report file consists of multiple information. They are: 
o Parameter values sent to the CreateAffyCustomCdf function. 
o Distribution of number of probes per probe set table. 
o The histogram of the number of probes per probe set. 
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o Number of probes aligned to an annotation. 
o Number of annotation detected by probes before probe sharing 
eliminated. 
• Missing Probes File: In some cases, the FASTA file of probes may include 
some probes that is not used in the original CDF. These probes are detected and 
placed into a text file to inform users. The name of the file starts with the 
original CDF name with postfix missingProbes. i.e 
Rat230_2.cdf_missingProbes.txt 
7.1.3 Running Time 
As long as the version of a genome and annotations are not changed, probe sets 
designed inside the custom CDFs are not required to be created more than one time 
providing that in Affymetrix® GeneChips® probes do not change. Therefore, long running 
time does not become an important issue. But still we know that short running time is 
always a positive feature to have in a tool. To achieve relatively fast tool, we took the 
advantage of NCList indexing and hash tables. Moreover, we implemented some part of 
the tool with C++ and combined these parts with R code. Table 11 shows the running time 
result in seconds performed on a computer with eight GB memory and 2.80 GHz CPU. 
TABLE 11: Running times 
 Region Based Gene Based Transcript Based 
Human U133 Plus 2.0 Array 23 min 23 min 4 min 
Rat Genome 230 2.0 Array 6 min 6 min 71.82 sec 










 In this section we demonstrate the remapping and probe set results for some of our 
custom CDFs. We also include analysis results performed by using our custom CDFs. The 
experiments were performed on the Affymetrix® GeneChip® HG-133 Plus 2, Rat 230 2.0. 
and Mouse 430 2.0. During the creation of custom CDFs, no direction rule is applied and 
junction is not allowed (see Section 7.1.1 custom CDF types). 
8.1 Probes Mapping to Genome 
Using the bowtie version 1.0.1 we were able to identify probes that uniquely map 
with 100% identity for each of the respective genomes. As a result, 87% PM probes of the 
HG-U133 Plus 2, 84% PM probes of the Rat 230 2.0 and 86% PM probes of the Mouse 
430 2.0 were uniquely mapped to the genome and were used in the subsequent steps (Table 
12). 
TABLE 12: Number of mapped probes for custom CDF construction 
GeneChip® 
# of PM 
Probes 
# of PM Probes 
Mapped Uniquely 
# of PM Probes 
Mapped to Multiple 
Locations 
# of PM Probes 
Not Aligned 
Human Genome U133 
Plus 2.0 Array 
603,158 525,985 364,93 406,80 
Rat Genome 230 2.0 
Array 
341,459 288,319 260,27 271,13 
Mouse Genome 430 2.0 
Array 
495,374 427,758 284,44 391,73 
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8.1.1 HG-133 Plus 2 
 Chromosome sequences of the human assembly 38 (October 2014) were obtained 
from the Ensembl ftp and bowtie indexes were created using bowtie-build version 1.0.1 
with default parameters. We also obtained the DNA sequences for perfect match (PM) 
probes of Affymetrix® GeneChip® HG-U133 Plus 2 from the Affymetrix® Netaffx™ web 
site as a FASTA file format. After we removed the control probes from FASTA file, we 
performed mapping of PM probes to the indexed genome using Bowtie version 1.0.1 
(parameters –v 0 – m 1). We filtered all the probes except those that aligned to one genomic 
location with 100% identity. As a result, 525,985 out of 603,158 PM probes uniquely 
mapped to the genome and were used in the next steps. 36,493 probes mapped to multiple 
locations and were removed. 40,680 PM probes did not align to the genome without 
mismatches and were also removed.  
8.1.2 Rat 230 2.0 
Chromosome sequences of rat assembly Rnor 6 were obtained from NCBI and 
created bowtie indexes using bowtie-build version 1.0.1 with default parameters. We also 
obtained the DNA sequences for the perfect match (PM) probes of Affymetrix® 
GeneChip® Rat 230 2.0 from the Affymetrix® Netaffx™ web site in FASTA file format. 
After we removed the control probes from the FASTA file, we performed mapping of PM 
probes to the indexed genome using Bowtie version 1.0.1 (parameters –v 0 – m 1). We 
filtered out all the probes except ones that aligned to one genomic location with 100% 
identity. As a result, 288,319 out of 341,459 PM probes uniquely mapped to the genome 
and were used in the next steps. 26,027 probes mapped to multiple locations and were 
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removed. 27,113 PM probes did not align to the genome without mismatches and also were 
removed. 
8.1.3 Mouse 430 2.0 
Chromosome sequences of Mouse assembly mm10 were obtained from the 
Ensembl ftp and created bowtie indexes using bowtie-build version 1.0.1 with default 
parameters. We also obtained the DNA sequences for the perfect match (PM) probes of 
Affymetrix® GeneChip® Mouse 430 2.0 from the Affymetrix® Netaffx™ web site in 
FASTA file format. After we removed the control probes from the FASTA file, we 
performed mapping of PM probes to the indexed genome using Bowtie version 1.0.1 
(parameters –v 0 – m 1). We filtered out all the probes except ones that aligned to one 
genomic location with 100% identity. As a result, 427,758 out of 495,374 PM probes 
uniquely mapped to the genome and were used in the next steps. 28,444 probes mapped to 
multiple locations and were removed. 39,173 PM probes did not align to the genome 
without mismatches and also were removed. 
8.2 Probe Annotations and Probe Sets 
 To annotate probes, we mapped uniquely aligned probes to gene regions using the 
Ensembl GTF file for each respective organism. We selected the specific regions from GTF 
based on the custom CDF type (gene, transcript or region-based). Consequently, we 






TABLE 13: Summary of probes used for custom gene and transcript based Custom CDFs 
 
 
Homo sapiens Rattus norvegicus Mus musculus 
Gene Transcript Gene Transcript Gene Transcript 
# of Probes 
Used 
414,701 504,419 162,356 205,671 323,917 395,884 
# of Probe Sets 
Constructed 
226,51 260,96 131,50 144,66 192,82 209,80 
Average # of 
Probes Per 
Probe Set 
18 18 12 14 16 18 
TABLE 14: Summary of probes used for region based custom CDFs 
 
 
Homo sapiens Rattus norvegicus 
Mus 
musculus 
# of Probes Aligned to Genome 822,681 321,905 637,942 
# of Probes Used 414,701 162,356 323,917 
# of Probe Sets Constructed 339,16 198,39 289,63 
Average # of Probes Per Probe 
Set 
12 8 11 
8.2.1 Detailed Results for HG-133 Plus 2 
 We used the Ensembl GRCh38 genome version’s GTF file for the annotations and 
created three different CDF files for future data analysis.  
I. Region Based Custom CDF 
 After mapping probes to the genomic regions, we identified 822,681 annotations (a 
probe aligned to a genomic region and marked with this region). The custom CDF has 
33,939 custom designed probe sets: 16,375 probe sets represent UTR regions and 16,024 
probe sets represents exon, plus 62 original control probe sets. 405,020 annotations were 
filtered.  
 Fig. 47 shows the distribution of probe numbers per probe set. The minimum probe 
number per probe set is 1, the average number of probes per probe set is around 12 and the 












II. Gene Based Custom CDF   
 The human gene based CDF has 22,651 custom designed probe sets composed from 
414,692 probes and 62 original control probe sets. 442,025 annotations were identified 
between genes and the probes. 27,324 annotations were filtered after shared probes were 
removed. 
In order to validate our probe set annotations, we compared the original CDF probe 
sets with the custom CDF. A total of 21,585 annotated genes were shared between the two 
CDFs, with 3,068 unique to the original CDF, and 1,066 unique to our custom CDF. We 
obtained the Ensembl id for each probe set from the Ensembl Funcgen database [109] using 
Perl scripts. Fig. 48 shows the comparison results. 85% (except control probes) of the 
original probe targets are preserved in the custom CDF.  
 
Figure 48: Original CDF versus custom CDF 
To determine why some genes were not covered in our CDF, we examined those 
unique to the original CDF. First, we obtained the probe sets which represent these genes 
in the original CDF, yielding 2,781 probe sets. We retrieved both the PM and MM probe 
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sequences for each of these. We observed that for 667 probe sets, every probe was removed 
during probe mapping to the genome due to either non-unique mappings or mapping rates 
less than 100%. 30,150 probes from the remaining 2,114 probe sets were not used in our 
CDF since they either did not map to the genome or they were MM probes. 14,028 probes 
were used in our newly constructed probe sets which target different genes than the original 
assignment by Affymetrix® and 2,656 probes were not aligned to gene structures and not 
annotated. As a result, the differences between the original CDF and our method occurs 
because of probes removed during genome alignment, probes that no longer map to gene 
structure or probes that map to gene structures different from the original annotation. 
 Fig. 49 shows the distribution of probe numbers per probe set. The minimum probe 
number per probe set is 1, the average number of probes per probe set is around 18 and the 






Figure 49: The distributions of probe numbers per probe set for the gene based CDF 
 We also compared our gene based CDF with the Brain Array Ensembl Gene version 
19 CDF (Fig. 50).  Most of the genes that were not included in our CDF were removed 
during the filtering of multiple annotated probes. A few of the missing genes are located 
on the mitochondrial Chromosome MT which is not included in our Bowtie index. We 
annotated an additional 2,758 genes. 
 
Figure 50: Original CDF versus the brain array CDF 
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III. Transcript Based Custom CDF  
 The unique probes transcript based CDF has 26,096 custom designed probe sets 
composed from 504,419 probes. We also included 62 original control probe sets. 2,129,643 
annotations were identified between transcripts and the probes. 
 Fig. 51 shows the distribution of probe numbers per probe set. The minimum probe 
number per probe set is one, the average number of probes per probe set is around nineteen 
and the median is eleven. 
 
 
Figure 51: The distributions of probe numbers per probe set for the transcript based CDF 
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8.3 Analysis Results 
 To test our custom CDFs, we reanalyzed the publicly available data series 
GSE72551 and GSE48611. Both studies involve the nervous system, where differences in 
3’ UTRs are likely to have phenotypic effects on transcript localization. We tested it on the 
publicly available data series. The GSE48611 data set was analyzed via HG-133 Plus 2  
custom CDFs. The GSE48611 was analyzed via Rat 230 2.0 custom CDFs. Prior to 
analysis, we removed probe sets with two or fewer probes from the custom CDFs in order 
to achieve more accurate results for target expression levels. Robust Multiarray Averaging 
(RMA) normalization was used for preprocessing. A p-value 0.05 was used as the threshold 
for all experiments. 
• Results for GSE48611 
The GSE48611 [63] was obtained from GEO. The data series examines Down 
Syndrome (trisomy 21) gene expression monitoring. They have collected mRNA samples 
from the isogenic trisomy of chromosome 21 (Ts21) and control pluripotent stem cells 
(iPSCs) (DS1, DS4, and DS2U) between passages 24 and 48 and from day 30 neurons. 
They have three biological replicates for each case. In our analysis we looked for the 
differentially expressed genes (DEGs) between isogenic Ts21 and control iPSCs for DS1 
and DS4. To identify the DEGs, we set an adjusted p-value threshold of 0.05 for all 
experiments and obtained the genes passing this threshold. Before starting the analysis, we 
removed the probe sets which have 3 or fewer probes per probe set from custom CDFs. 
First, we analyzed the data based on our gene based custom CDF and the original 
Affymetrix® supplied CDF obtained from the Affymetrix® Netaffx™ web site. For DS1, 
our gene based CDF identified 814 DEGs, while the original CDF identified 2,402 DEGs 
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with 625 DEGs identified by both methods (Fig. 52). Table 15 shows the top ten DEGs 
and their ranking in the original method results. Since the original CDF has multiple probe 
sets per gene, we only reported the top ranking for each gene and adjust the rankings. We 
have two genes (ZNF717, ZNF560) in our top ten list from qPCR verified genes which is 
supplied in the original paper.  
We repeated the same analysis for DS4 versus DS2U. Our gene base CDF identified 
621 DEGs, while the original CDF identified 1,819 unique DEGs with 379 DEGs identified 
by both methods (Fig. 53). Table 16 shows the top ten DEGs based on our CDF and their 
adjusted ranking in the original method results. We have three genes (ZNF717, ZNF560, 
CRYZ) in our top ten list from qPCR verified genes which is supplied in the original paper. 
Eight genes were commonly expressed for DS1 and DS4. 
 






TABLE 15: DS1 versus DS2U top ten DEGs 
 Our Method Original Method 
Gene  Id logFC adj.P.Val Ranking logFC adj.P.Val 
ZNF667-AS1 5.682693 1.50E-08 1 5.617611 5.53E-09 
CTSF 1.906976 4.24E-08 2 2.074571 2.89E-08 
ZNF667 3.579938 4.19E-07 4 3.910541 8.74E-07 
ZNF717 3.209391 6.06E-07 16 2.355922 2.96E-05 
NNAT 3.445 2.62E-06 18 2.125069 3.45E-05 
ZNF560 2.764886 5.54E-06 7 2.638967 1.97E-06 
TMSB15A -2.28818 6.54E-06 NA NA NA 
ZNF578 1.990097 1.80E-05 19 1.940997 3.52E-05 
ZNF239 -2.1717 1.80E-05 13 -2.19910 2.39E-05 
PAXBP1 1.057482 1.86E-05 23 1.000226 4.57E-05 
 
 







TABLE 16: DS4 versus DS2U top ten DEGs 
 Our Method Original Method 
Gene Id logFC adj.P.Val Ranking  logFC adj.P.Val 
ZNF717 3.316176 1.50E-06 8 2.564958 2.25E-05 
ZNF667-AS1 3.97883 1.57E-06 1 3.996053 1.14E-06 
NNAT 3.591202 2.38E-06 10 2.221193 4.02E-05 
ZNF578 2.205069 8.71E-06 7 2.167641 2.25E-05 
CTSF 1.233071 1.04E-05 6 1.292598 1.34E-05 
NLRP2 1.575696 1.04E-05 5 3.454983 8.77E-06 
PAXBP1 0.977935 7.41E-05 19 0.862839 0.000480611 
CRYZ 5.230353 7.41E-05 11 5.240513 7.67E-05 
ZNF560 2.220455 8.07E-05 9 2.166272 3.74E-05 
SRP19 -0.86613 0.000161 33 -0.81259 0.001628958 
 
We analyzed DS1 versus DS2U via our region based CDF as well. The CDF 
identified 1,494 DE gene regions. 56 DE gene regions target the same gene but different 
regions (UTR and exon) (Fig. 54).  698 of them only come from UTR and 740 of them did 
not have probe sets in UTR region (i.e. they only come from exon regions). Fig. 55 shows 
the result for DS4 versus DS2U. 
 




Figure 55: Distributions of probe set regions in the DS4 versus DS2U DEGs 
 In order to see how the region based CDF changes the analyses, we took the 
Ensembl id of every region probe set and compared them with the Ensembl id of the gene 
based result (Fig. 56, Fig 57). It showed that the number of commonly detected DEGs is 
small compared to the number of detected DEGs in each case.   
 
Figure 56: Distribution of common and different DEGs for our gene and gene region 




Figure 57: Distribution of common and different DEGs for our gene and gene region 
based methods in the DS4 versus DS2U case 
 Table 17 shows the top ten DEGs for DS1 versus DS2U. Table 18 shows the top 
ten DEGs for DS4 versus DS2U. In the case of Ds4 versus the DS2U region based three 
genes of top ten are same with D1 versus DS2U region based. 
TABLE 17: DS1 versus DS2U top ten region based DEGs 
  Region Method Gene Method 
Probe Name Gene Id logFC adj. P.Val Ranking  adj.P.Val 
ENSG00000154646_UTR_- TMPRSS15 1.618164 4.33E-06 13712 0.763167 
ENSG00000143473_exon_- KCNH1 1.506579 4.33E-06 15435 0.825465 
ENSG00000135916_UTR_+ ITM2C 3.143009 1.77E-05 7385 0.468028 
ENSG00000232837_exon_- AF064858.7 1.312395 0.000157 12364 0.709271 
ENSG00000122085_exon_- MTERFD2 1.582542 0.000157 6532 0.419254 
ENSG00000229913_exon_- RP11-378I13.1 1.778681 0.000157 13950 0.771693 
ENSG00000184361_UTR_- SPATA32 0.896036 0.000157 21500 0.998295 
ENSG00000224418_exon_+ STK24-AS1 0.912373 0.000192 12250 0.704311 
ENSG00000174915_UTR_+ PTDSS2 1.644557 0.000215 10517 0.630927 





TABLE 18: DS4 versus DS2U top ten region based DEGs 
  Region Method Gene Method 
Probe Name Gene Id logFC adj P.Val Ranking  adj. P.Val 
ENSG00000154646_UTR_- TMPRSS15 1.117224 0.000477 859 0.058301 
ENSG00000215644_exon_+ GCGR 5.114162 0.000477 18359 0.921109 
ENSG00000143473_exon_- KCNH1 1.044703 0.000477 14504 0.790649 
ENSG00000265491_exon_- RNF115 -1.2177 0.000557 16520 0.862608 
ENSG00000224418_exon_+ STK24-AS1 0.857835 0.000603 15478 0.828281 
ENSG00000160294_exon_- MCM3AP 1.042106 0.000603 123 0.010939 
ENSG00000113384_UTR_- GOLPH3 1.170004 0.000737 18153 0.799779 
ENSG00000132016_UTR_- C19orf57 1.451636 0.000831 8375 0.505504 
ENSG00000099219_UTR_- ERMP1 -0.98893 0.000869 16003 0.849883 
ENSG00000227234_exon_+ SPANXB1 -1.01635 0.000869 19103 0.941769 
We also used the Brain Array Ensembl Gene version 19 custom CDF to compare 
our method’s gene based results. 712 genes detected as DE by both methods (Fig. 58). Our 
method detected 189 unique DEGs and Brain array detected 182 unique DEGs. 
 






TABLE 19: D1 versus DS2U top ten upregulated genes Brain Array Ensembl V 19 
External Id logFC adj.P.Val Our Method Rank 
CTSF 1.897594 1.06E-07 2 
ZNF667 3.530854 6.31E-07 3 
ZNF667-AS1 5.134179 1.22E-06 1 
NNAT 2.84469 2.68E-06 5 
ZNF560 2.741947 6.39E-06 6 
TMSB15A -2.29051 6.89E-06 7 
ZNF239 -2.27282 6.89E-06 9 
PAXBP1 1.129587 1.52E-05 10 
ZNF578 1.986575 1.68E-05 8 
UTY 1.968354 2.81E-05 11 
 Nine out of ten genes correlate with our results. The UTY gene is detected as the 
11th DEG. 
• Results for GSE72551 
 The GSE72551 data series examines gene expression changes associated with 
collateral sprouting and includes 5 naive controls, 7 replicates at day 7 post-surgery and 7 
replicates at day 14 post-surgery. In our analysis we looked for the differentially expressed 
genes (DEGs) between 0-7 and 0-14. To identify the DEGs, we set a p-value 0.05 as the 
threshold for all experiments and obtained the genes passing this threshold. Before starting 
the analyses, we removed the probe sets which have less than three probes from custom 
CDFs. First, we analyzed the data based on our gene based custom CDF and original 
Affymetrix® supplied CDF obtained from the Affymetrix® Netaffx™ web site. For 7 
versus 0, our gene base CDF identified 981 DEGs; original CDF identified 1,695 unique 
DEGs. 750 DEGs identified by both methods (Fig. 59). Table 20 shows the top ten DEGs 
and their ranking in the original method results. For 14 versus 0, our gene base CDF 
identified 1,948 unique DEGs, original CDF identified 3,484 unique DEGs. 1,560 DEGs 
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identified by both methods (Fig. 60). Table 21 shows the top ten DEGs and their ranking 
in the original method results. 
 
Figure 59: Typical method versus our method for day 7 versus naive 
 







TABLE 20: Day 7 versus naive top ten DEGs 
 Our Method Original Method 
Gene  Id logFC P.Val Ranking logFC P.Val 
Slc41a2 0.327865 1.87E-05 5 0.331196 4.05E-05 
Txnrd1 0.30567 2.16E-05 13 0.323269 7.61E-05 
Nppa 0.400947 4.26E-05 8 0.410406 5.19E-05 
Grhl3 -1.11758 4.97E-05 3 -1.02727 2.80E-05 
Bdnf 0.754445 5.93E-05 10 0.793467 6.86E-05 
Rasgrp2 -0.34898 6.34E-05 45 -0.38074 0.000517 
Abca8a -0.29425 0.000104 15 -0.28487 0.000117 
Pdzd3 -0.37835 0.000114 11 -0.38425 6.98E-05 
Gabra5 0.721666 0.000138 15 0.742534 8.59E-05 
Cat -0.29616 0.000156 22 -0.29166 0.00021 
 
TABLE 21: Day 14 versus naive top ten DEGs 
 Our Method Original Method 
Gene  Id logFC P.Val Ranking logFC P.Val 
AABR07026969.1 -0.56774 8.43E-07 5 0.331196 4.05E-05 
Bbs5 -0.54004 6.47E-06 27 -0.4116 2.94E-05 
Pde7b 0.374652 7.25E-06 29 0.339101 3.49E-05 
Epb41l4a -0.37437 1.58E-05 16 -0.3719 1.41E-05 
Tgs1 -0.39079 1.95E-05 35 -0.38539 5.32E-05 
Txnrd1 0.307737 1.99E-05 64 0.308068 0.000131 
Pcsk6 -0.28696 2.37E-05 24 -0.28712 2.77E-05 
Wdr75 -0.3425 2.40E-05 34 -0.38832 5.17E-05 
Tmem18 -0.37817 3.31E-05 2018 -0.23385 0.009632 
Cish 0.293301 4.15E-05 162 0.41206 0.000387 
 
We analyzed the data via region based CDF as well. For condition 7, the CDF 
identified 1,350 DE gene regions. 94 DE gene regions target the same gene but different 
regions (UTR and exon) (Fig. 61).  695 of them only come from UTR and 561 of them did 




Figure 61: Distributions of probe set regions in the 7 versus naive DEGs 
For condition 14, the CDF identified 2,573 DE gene regions. 248 DE gene regions 
target the same gene but different regions (UTR and exon) (Fig. 62).  1349 of them only 
come from UTR and 976 of them did not have probe sets in UTR region (i.e. they only 
come from exon regions). 
 
Figure 62: Distributions of probe set regions in the 14 versus naive DEGs 
 In order to see how the region based CDF changes the analyses, we took the 
Ensembl id of every region probe set and compared them with the Ensembl id of the gene 
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based result (Fig. 63, Fig. 64). It showed that the number of common detected DEG is small 
compare to number of detected DEGs in each case.    
 
Figure 63: Distribution of common and different DEGs for our gene and gene region 
based methods in the 7 versus naive case 
 
Figure 64: Distribution of common and different DEGs for our gene and gene region 
based methods in the 7 versus naive case 
 Table 22 shows the top ten DEGs for 7 versus naive. Table 23 shows the top ten 
DEGs for 14 versus naive.  
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TABLE 22: 7 versus naive top ten region based DEGs 
  Region Method Gene Method 
Probe Name Gene Id logFC P.Val Ranking  P.Val 
ENSRNOG00000018225_UTR_+ Tp53inp2 0.445475 2.34E-05 7909 0.573936 
ENSRNOG00000002327_UTR_- Gabrb1 0.813037 2.69E-05 10404 0.805792 
ENSRNOG00000045989_exon_- LOC287167 0.628027 3.07E-05 8949 0.666452 
ENSRNOG00000020076_exon_+ RGD1311783 0.32314 4.15E-05 738 0.03043 
ENSRNOG00000002336_exon_+ Gabra4 0.736634 4.47E-05 2792 0.155193 
ENSRNOG00000016847_UTR_+ Bace1 0.756573 5.99E-05 6593 0.46302 
ENSRNOG00000014312_exon_+ TRBC2 -0.87884 7.60E-05 8180 0.596293 
ENSRNOG00000060599_UTR_+ Gabrb3 0.645368 0.000113 1281 0.058284 
ENSRNOG00000006027_exon_+ Eif2ak4 0.308961 0.000129 6730 0.476479 
ENSRNOG00000010361_UTR_+ Kif3b 0.23965 0.000148 4056 0.251742 
 
TABLE 23: 14 versus naive top ten region based DEGs 
  Region Method Gene Method 
Probe Name Gene Id logFC P.Val Ranking  P.Val 
ENSRNOG00000020877_UTR_- Pyy -0.77755 5.943563 521 0.005948 
ENSRNOG00000024452_UTR_+ Rltpr -0.60557 6.594111 9979 0.681486 
ENSRNOG00000054080_exon_- Cgnl1 -0.45831 8.026746 11422 0.861384 
ENSRNOG00000060931_exon_- Rspy1 -0.36454 10.27095 1096 0.017312 
ENSRNOG00000002327_UTR_- Gabrb1 0.839938 8.305223 2309 0.051623 
ENSRNOG00000015231_UTR_+ Mrpl44 0.284317 9.885974 7862 0.446372 
ENSRNOG00000025496_exon_+ Usp7 -0.72064 5.742713 8428 0.501202 
ENSRNOG00000002336_exon_+ Gabra4 0.773239 8.259599 301 0.00283 
ENSRNOG00000013956_exon_- Rnf38 -1.34435 6.044207 9180 0.586421 
ENSRNOG00000014312_exon_+ TRBC2 -0.94034 5.994768 2577 0.062007 
 
 
We also reanalyzed the data using brainarray Ensembl CDF version 20. Fig. 65 
shows a Venn diagram representing the number of differentially expressed genes using 
region, gene and brainarray custom CDFs for both cases. 
Further examination of the 7 day versus naive ENSEMBL genes found to be 
differentially expressed in either the gene-based or region-based CDF shows high 
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concordance, with 975 ENSEMBL genes determined to be differentially expressed using 
both CDFs (Fig. 65a). Examination of the p-values shows a significant correlation between 
both the gene and the 3’ UTR region (r=0.439; p=1.480E-58) as well as the gene and the 
exon region (r=0.101; p=0.001). The higher correlation with the 3’ UTR region is to be 
expected, due to a higher abundance of probes designed in these regions. 
160 genes are found to be differentially expressed using the gene-based approach 
only, with three not included in the region-based CDF. Further examination shows that 122 
of these (78%) have a gene-based pvalue > 0.03, and 80 (50%) have a gene-based p-value 
> 0.04, indicating the detected differences are just below the cutoff level. Analysis of the 
region-based p-values show that 120 of these (77%) have a region based p-value < 0.10, 
and 146 (94%) have a region-based p-value < 0.20, putting these genes just above the 
significance threshold. 
An additional 423 genes are found to be differentially expressed using the region-
based approach only, with 203 from the 3’ UTR only, 10 from the 5’ UTR only, 206 from 
the exon only, and 4 from both the 3’ UTR and exon. Unlike the DEGs uniquely found in 
the gene-based approach, those genes found to be differentially expressed in the region-
based approach typically have a much higher p-value in gene-based analysis, with only 
31% having a p-value between 0.05 and 0.10. This supports our reasoning that separating 
into functional regions allows detection of subtle changes in transcript formation that may 
have a larger functional impact of those transcripts which has been further validated by 
experimental work showing differential expression of the 3’ UTR of the CAMKIV gene 




Figure 65: Number of common and different differentially expressed genes using region, 
gene and brain array custom CDFs. a Day 7 versus naïve. b Day 14 versus naive 
In order to determine why some genes were only detected by brainarray, we 
examined probes of those genes. 39 probes were not used in our CDFs since they aligned 
to multiple locations in the rn6 genome. 10 probes did not match gene structures in Ensembl 
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and were not used in the CDFs. 18 probes were removed because the probe set contained 
fewer than three probes. 40 probes were used in different probe sets other than those 
annotated by brainarray. 
8.4 Conclusions 
One of the limitations of microarray technologies is the design of probes based on 
available sequence and annotation data at the time of design. Based on our analysis, the 
percentage of uniquely mapping probes varies from 84% (rat) to 87% (human), indicating 
that changing knowledge about the genome itself plays a role in probe utilization. In terms 
of annotation, the rat genome is known to have more incomplete information when 
compared to mouse and human, which is reflected in the fact that only 47% of the rat probes 
lie in region-based locales (exons and UTRs) compared to 65% for mouse, and 69% for 
human. Since this can potentially lead to a small number of probes in each annotated region 
(and thus increased false positive rates), we have further required at least three probes be 
present in each probe set for our analysis. To further illustrate the importance of region-
based CDFs, using the subset of 4,024 genes with probesets in both the individual exon 
and 3’ UTR regions, we were able to identify 203 differential expression events at the 3’ 
UTR level that do not show differential expression within the exon. In addition, these 
events are not detected using the standard Affymetrix® CDF. Further analysis of these 203 
genes yields some genes of particular interest. For instance, the 3’ UTR of GRIK4 
(Glutamate Ionotropic Receptor Kainate Type Subunit 4) was up-regulated (p-value 
0.0450) while the CDS was not significantly regulated (FC=1.07; p-value 0.4525), 
suggesting the 3’ UTR of this gene was lengthened (Fig. 66). GRIK4 regulates kainite-
receptor signaling and neuroplasticity [111] and its missregulation is associated with 
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neurological diseases including Alzheimer’s, bipolar disorder [112], and others. 
Interestingly, a deletion variant specific to the 3’ UTR of GRIK4 is protective of bipolar 
disorder[112]. Alongside our observation, this shows an example of how a gene can be 
regulated through the 3’ UTR. We also observed that the 3’ UTR of VEGFA (vascular 
endothelial growth factor-A) was downregulated (-1.17 FC; p=0.0102) and expression of 
its CDS was unchanged (1.01 FC; p=0.8334) (Fig. 66). The 3’UTR of VEGFA, a potent 
neuromodulator, undergoes a well-described binary switch to regulate its expression [113]. 
Our observations suggest the VEGFA 3’ UTR undergoes an additional layer of regulation 
by shortening during collateral sprouting.  
As our analysis with the GSE48611 and GSE72551 datasets show, reanalysis of 
publicly available datasets using updated annotations can yield additional information 
when compared to the use of the original CDFs. In our case, the region-based CDFs allow 
for a better understanding of 3’ UTR dynamics through the reanalysis of publicly available 
data. While current high-throughput sequencing technologies may allow for a more 
complete picture, this custom CDF approach will allow for deeper insight with only 











CONCLUSIONS AND FUTURE DIRECTIONS 
 Microarrays were designed to examine the gene expression at the level of exons 
and genes but they do not examine the genes at the untranslated regions (UTRs). 
Additionally, they do not supply gene expression on transcript levels. Several researchers 
have called attention to the importance of getting expression levels for a specific transcript 
and created their own Chip Description Files (CDFs) to redesign probe sets. However, to 
this point in time analyses at the level of UTRs and individual exons has been minimal. It 
has been revealed that the untranslated regions of mRNA can dramatically change the 
regulation of protein and result in abnormal cell functions later on diseases. For that reason, 
achieving genome based screening of publicly available microarray data at the level of 
gene regions is important. Moreover, one of the limitations of microarray technologies is 
the design of probes based on available sequence and annotation data at the time of design. 
Based on our analysis, the percentage of uniquely mapping probes varies from 84% (rat) 
to 87% (human), indicating that changing knowledge about the genome itself plays a role 
in probe utilization. The significant differences between old and new genome assemblies 
and annotations make it necessary to update probe-gene targeting according to current 
knowledge to get more accurate interpretations from experimental results.  In order to make 
it these possible, we created new CDFs by reassigning probes at the level of UTRS and 
individual exons. Moreover, we developed a tool for dynamically creating custom CDFs
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 based on the user’s interest. We believe that our work will help researchers to reexamine 
already analyzed data in a different way 
9.1 Summary of Contributions 
• We developed an Affymetrix® GeneChip® probe remapping protocol at the level of 
genes, transcripts, untranslated regions (UTRs) and individual exons based on the latest 
genome (hg38, mm10, rn6) and Ensembl annotations for human, mouse, and rat. Our 
results illustrated how this framework affects the detection of differentially expressed 
genes, particularly when focusing on functional regions of interest. Removing probes 
that do not perfectly align to the genome or align to multiple locations can help to 
reduce false-positive differential expression, as can removal of probes in regions 
overlapping multiple genes. 
• The main motivation of our work was profiling the contribution of UTR and exon 
regions to the gene expression levels globally. Our results indicate that features 
differentially expressed in either the gene-based or region-based CDF shows high 
concordance and separating out into functional regions allows for the detection of 
subtle changes in transcript formation. 
• Our method can detect changes that would have been missed if the analysis was not 
separated into functional regions. For example, as shown in fig. 66 the 3’ UTR of the 
VEGFA gene upregulates between day zero to day seven, however the exon regions of 
the VEGFA does not show a significant change.  
• We developed an R package, affyCustomCdf, for allowing users to dynamically create 
custom CDFs. This is important since genomic knowledge grows and improvs very 
fast. For example, when we performed analyses with our custom CDFs, the latest 
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Ensembl version was 85. Currently, Ensembl version 92 is available. Through the 
dynamic nature of our tool affyCustomCdf, user can easily benefit from the 
improvement over genomic knowledge and keep custom CDFs updated. 
• Our custom CDF approach allows for deeper insight with only minimal computational 
cost, taking advantage of the high volume of publicly available GeneChip® data. 
9.2 Post Dissertation Work 
9.2.1 Dealing with Dynamic Biological Initializers   
Some of the probe sequences may contain single nucleotide polymorphisms (SNPs) 
or may map to gene regions that produce variations of RNA products through a molecular 
process called RNA editing. It would be informative to query these probes and inform 
scientists about possible RNA editing effects within their analysis. These probes can be 
detected by mapping probes to the RNA editing site and SNP databases such as dbSNP. 
After identification of such probes, a special naming pattern could be used to mark probe 
sets containing these probes. Moreover, alternative probe sets can be created via modifying 
probes based on known RNA editing sites and SNPs and placed into custom CDFs. 
9.2.2 Conservation of Gene Annotation 
 Some species or some genes of a species might be studied and annotated less than 
others. The number of annotated regions in a genome effect the number of probes used in 
a CDF because the probes that align to an unannotated region are going to be discarded in 
the proposed method. As seen in table 24 the number of probes annotated to a specific 
region is higher for the human genome which is well studied while there is likely to be 
differences in the number and construction of the gene between human and rat, the 
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transcriptomes are still highly similar. The most likely reason for the difference is 
incomplete annotation for rat.  
TABLE 24: The number of probes per region and transcript after the annotation step 
 UTR CDS Exon Transcript 
Human 268,863 108,960 440,252 2,129,643 
Rat 100,774 56,425 163,498 275,588 
 In order to overcome the issue and gain discarded probes back, one can provide 
annotations to nonannotated regions of conserved genes across species by converting 
genome coordinates and genome annotations between two or more species.  
 For example, Fig. 67 shows the alignment of Affymetrix® Rat 230 2.0 probes that 
targets the Camk4 gene. The probes (ending in _at) do not align to an annotated region of 
the rat and human genomes, but the mouse genome has a long UTR region annotation. If 
one can use annotations obtained from the mouse genome and apply them to the rat and 
human genomes, more probes can be added into probe sets. 
 
Figure 67: Genome browser view of the gene Camk4 with probes  
 Fig. 68 shows the alignment of Affymetrix® Rat 230 2.0 probes that target the 
Otud7a gene. In this case, both the human and mouse genomes have annotations for 
the probes. When the probes are aligned to the rat genome, they do not match to an 





Figure 68: Genome browser view of the gene Otud7a with probes 
One way to accomplish this mapping is: 
I. Retrieve the annotation file for a species from the genome browser.  
II. Convert the annotation coordinates to another genome via the Lift Genome 
Annotations tool provided by the UCSC Genome browser.  
III. Use new annotations during the probe to annotation alignment. 
9.2.3 Disease Drug Network Establishment Based on Genomic Expression 
Profiles 
 UTR region sequence and structure can dramatically change the regulation of a 
protein and result in abnormal cell functions and diseases. Our region based CDFs can be 
used to monitor the changes of UTR regions with different disease states and drug effects 
via analyses of whole-genome gene expression data available in the public repositories. 
The obtained expression profile similarities of diseases and drugs can be used to generate 
large scale disease-disease, drug-drug and disease-drug networks. A similar work has been 
done by Hu et al. They collected GEO datasets that is biologically and statistically 
comparable samples produced via same Affymetrix® GeneChip®. To avoid having 
multiple probe sets for a gene, they blasted probes of each probe set to NCBI RefSeq 
database. Based on the average distance of eleven probes to the 3ꞌ end, they classified probe 
sets and picked one probe set for each gene. Their first preference for the probe set selection 
is the one located on the 3ꞌ UTR, and they continued selection based on the shortest distance 
to the 3ꞌ UTR. Via analyses they generated disease and drug expression profiles from GEO 
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datasets and generated a large scale disease- drug network. They point out that the network 
can help finding new targets to existing drugs in a cost efficient way and drug 
target/pathway identification. Similar work can be done via our region based custom CDF 
for only untranslated regions of gene to reveal more information about UTRs, diseases and 
drugs relationship.  
9.2.4 Untranslated Regions Gene Expression Profiling  
 Microarrays profile the relative differences in gene expression rather than absolute 
gene expression detection. Only genes that significantly vary between samples within an 
experiment are detected and the rest of the genes are ignored. Because of unknown and 
variable sensitivity of each probe set, microarrays do not guarantee that every probe set has 
the same dynamic range of gene expression values. As a result of it, comparison made 
between genes with different dynamic ranges does not supply accurate results. Creating a 
common gene expression profiling from publicly available microarray data via meta-
analyses can provide an advantage for more accurate gene expression proofing. Such as a 
dynamic range interval can be calculated for each probe set of a specific microarray 
platform and the new experiment results can be judged based on the common reference. 
Creating common reference to normalize large amount of microarray data was already 
developed by many different groups. For example, Seita et al. [48] created an open platform 
for Affymetrix® mouse genome and made it available via a web site 
(https://gexc.stanford.edu/). But none of them analyzed the microarray data based on the 
regions of genes. One can use our region based custom CDFs file to achieve common gene 
expression profiling for untranslated regions of genes which can give a big advantage for 
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APPENDIX A  
AffyCustomCdf PARAMETERS 
A.1 Original CDF 
The original CDF of the selected Affymetrix® GeneChip® microarray must be 
supplied to the tool by the user. It is used as a source to obtain control probes and PM and 
MM tbase and pbase probe information. It is taken via orginalCdfName parameter. It can 
be obtained from Affymetrix® NetAffxTM or GEO. As an example, the original CDF file 
for Rat 230 2.0 is included inside the scripts directory of the github repository branch 
affyCustomCdfFull. 
(https://github.com/UofLBioinformatics/affyCustomCDF/tree/affyCustomCdfFull) 
A.2 Probe Alignment File 
The affyCustomCdf expects probe mapping as a text file. The probe mapping file 
consists of one line per probe, each containing five columns of data. Columns must be tab 
delimited without a header line. Columns are in the following order: x location of a probe, 
y location of a probe, sense/antisense of a probe (-/+), chromosome name and chromosomal 
starting location. Fig. 69 demonstrates first ten lines of the Rat 230 2.0 microarray probe 





Figure 69: First ten lines of the Rat 230 2.0 microarray probe mapping file 
A.2.1 Recommended probe mapping text file creation  
The DNA sequences for perfect match (PM) probes is obtained from the 
Affymetrix® NetaffxTM web site in a FASTA file format. PM probes are aligned to the 
genome using Bowtie version 1.0.1 with the parameters -v 0 and -m 1 which returns the 
alignment results for the probes that align to one genomic location with 100% identity. 
Also, the suppress parameter can be used to eliminate some output for clarity. The 
following command line is an example for aligning Rat 230 2.0 PM to Rat assembly rn6. 
It suppresses the 5th, 6th and 7th default Bowtie outputs. 
 
Figure 70: Bowtie command line for probe mapping 
If the index of the intended genome of an organism is not supplied by Bowtie, the 
assembled unmasked genomic DNA sequences of every chromosome can be downloaded 
from one of the online repositories such as Ensembl and NCBI and indexes can be created 
from DNA sequences via Bowtie-Build version 1.0.1 with default parameters. Fig. 71 show 




Figure 71: Mapping result of Bowtie for Rat 230 2. microarray 
The file can be formatted via an R script to obtain the proper column arrangement 
(Fig. 72). More script examples and data files can be found under the scripts folder of the 
github repository branch affyCustomCdfFull with the file name ProbeFileClear.R. 
 
Figure 72: Example R code for clearing Bowtie mapping results 
A.3 Obtaining annotation file  
The affyCustomCdf tool accepts annotations as a General/Gene Transfer Format 
(GTF). In the GTF file, fields must be tab delimited. The GTF format consist of nine 
columns of data per feature. The columns are seqname, source, feature, start, end, score, 
strand, frame and attribute. Comment lines in the file must start with #. The feature column 
is being used to classify probes for gene features. Therefore, region features must contain 
transcript, EXON, CDS and UTR key words (not case sensitive). If separation between 3‘ 
UTR and 5‘ UTR is desired, features must include the direction information such as 
three_prime_utr or five_prime_utr. Otherwise annotation will be performed without 
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classification of 3‘and 5‘. For more information please check the Ensembl GFF/GTF file 
format definition. http://www.ensembl.org/info/website/upload/gff.html. A sample GTF 
file can be found in the scripts directory of the github repository branch 
affyCustomCdfFull. 
A.4 Selecting Parameters 
The affyCustomCdf tool takes thirteen parameters. This includes the original CDF 
(Section A.1), probe alignment file (Section A.2) and annotation (GTF) file (Section A.3) 
which must be supplied by the user. The remaining parameters are optional, with default 
value set. The parameters are: 
• orginalCdfName: String type. The original CDF file of the selected Affymetrix® 
GeneChip® technology. It can be obtained from Affymetrix® NetAffxTM web site. For 
example, Rat230_2.cdf file for the Rat 230 2.0 microarray. 
• probeAlignmentFile: String type. The tab separated probe alignment file. Please see 
section A.1 for more details. 
• gtfFileName: String type. The General/Gene Transfer Format (GTF) file name. Please 
see section A.3 for more details. 
• newCDFName: String type. Name of the created custom CDF. If the user does not 
provide a name, a name will be created based on the template provided in Fig. 73. 
• reportFile: String type. Name of the report file name. If the user does not provide a 




Figure 73: File naming for custom CDFs 
• controlProbeSetNumber: Number type. The number of control probe sets in the 
original CDF. Control probe sets were being designed to check the quality of the 
experiment. They can be detected in the CDF based on the probe set names which 
usually starts with AFFX prefix such as AFFX_ratb2/X14115_at. If the number of 
control probe set is given, they will be included in the custom CDF without changes 
otherwise they will not be included. The default value is 0 (not included). 
• minProbeSetNumber: Number type. The minimum number of probes in a probe set. 
Probe sets with less than the minimum number will not be included in the custom CDF. 
The default value is three. 
• probeLength: Number type. Number of bases in a probe. In most cases length of a 
probe is twenty-five. For different sizes, it can be obtained via checking a sequence of 
a probe belongs to an Affymetrix® GeneChip®. The default value is 25. 
• SD: Number type. Sense/antisense relationship between probes and annotations. 
Possible values are 0 (no direction), 1 (same direction) and any value except 0 and 1 
(opposite direction). The default value is 1 (Same direction). 




o When SD is 1, mapping is performed between same directions such as the sense 
probes are being mapped to the sense annotations. 
o When SD is any value except 0 and 1, mapping is performed between opposite 
directions such as the sense probes are being mapped to the anti-sense 
annotations. 
• type = “regionG”: String type. The type of the created custom CDF. Options are 
regionG, gene, transcript. Default value is regionG. G 
o regionG: When regionG option is selected, probe sets are designed to target a 
specific region (exon, UTR) of a gene and consist of probes which map to the 
same region of a gene. 
o gene: When regionG option is selected, probe sets are designed to target genes 
and consist of probes which map to the same gene. 
o transcript: When transcript option is selected, probe sets are designed to target 
transcripts and consist of probes which map to the same transcript.  
• transcriptShare: Bool type. It defines whether to allow probe sharing between 
transcripts of a gene. It can only be used when transcript type is selected. Possible 
values are FALSE for not allowing probe share and TRUE for allowing probe share. 
The default value is FALSE. 
• junction: Bool type. It defines whether we are adding probes to probe sets that map 
onto a junction of a specific region of a gene. It can be used when regionG or gene 
option is selected. Options are FALSE for no junction and TRUE to allow junctions. 
The default value is FALSE. 
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• uniqueProbe: Bool type. It defines whether to use probes that map onto more than one 
annotations. It is an option for the user to examine unique probes to one specific 
annotation. It can only be used with the regionG type. Possible values are FALSE for 
not unique, TRUE for unique. The default value is FALSE. 
A.5 Running The affyCustomCdf Tool  
To create a custom CDF via affyCustomCdf tool, one must call the 
createAffyCustomCdf function after installation of the tool. Fig. 74 shows example R 
scripts. 
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